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PREFACE
Peptic ulceration and it*s complications result in 
a great deal of morbidity and mortality. The discovery 
of Helicobacter pylori has given us an opportunity to 
alter the natural history of peptic ulceration. This 
exciting possibility got me interested in Helicobacter 
pylori.
All the studies included in this thesis have been 
published. Advice and assistance of various colleagues 
was sought and these have been acknowledged. The 
studies in this thesis as well as writing of them was 
entirely my own work.
Ravi Shankar Chittajallu November 1994
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ABSTRACT
Chronic Helicobacter pylori infection of the 
gastric antrum is seen in over 95% of duodenal ulcer 
patients. Eradication of this infection results in a 
lowering of circulating gastrin concentration. A 
considerable proportion of the population are infected 
with H.pylori but only some of them develop duodenal 
ulceration. In this thesis I looked at the possibility 
that the development of duodenal ulceration in 
subjects with H.pylori infection is determined by the 
degree of hypergastrinaemia induced. In addition, I 
attempted to determine the mechanism by which this 
hypergastrinaemia may be brought about.
Consistent with earlier studies eradication of 
H.pylori infection in duodenal ulcer patients resulted 
in a fall in both basal and meal stimulated plasma 
gastrin concentrations. These values were similar in 
H.pylori positive duodenal ulcer patients and 
H.pylori positive asymptomatic volunteers. This 
suggests that factors in addition to elevated plasma 
gastrin are responsible for predisposition to duodenal 
ulceration in these patients.
The mechanism by which H.pylori infection induces 
hypergastrinaemia is unclear. It has been postulated 
that by virtue of its high urease activity the 
organism produces ammonia locally at the gastric 
antrum and this may directly stimulate gastrin release 
by the G cells or may act indirectly by elevating 
antral surface pH. There was, however, no change in 
plasma gastrin concentrations with either increased 
bacterial ammonia production by intragastric urea 
infusion or suppression of bacterial urease activity 
by triple therapy (amoxycillin, metronidazole, 
tripotassium dicitrato bismuthate). In addition, 
examining the effect of gastric alkalinisation on basal 
and meal stimulated plasma gastrin concentrations 
before and after eradication of H.pylori did not 
support this hypothesis. It was also noted that 
reversal of the acute inflammatory component of the 
antral gastritis produced by the infection is not 
associated with a change in plasma gastrin 
concentrations.
The possibility that the hypergastrinaemia is a 
physiological response to inhibition of parietal cell 
function by H.pylori was examined. There was no change 
in parietal cell sensitivity to pentagastrin after 
eradication of H.pylori. The mechanism by which chronic 
H.pylori infection of the gastric antrum induces 
hypergastrinaemia remains unclear. Further research is 
needed to elucidate this.
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SUMMARY
Helicobacter pylori infection of the gastric 
antrum is seen in over 95% of patients with duodenal 
ulceration. Eradication of the infection reduces ulcer 
relapse rate. The mechanism by which this infection 
predisposes to duodenal ulceration is not known.
Eradication of H.pylori infection in duodenal 
ulcer patients resulted in a fall in basal and meal 
stimulated plasma gastrin concentrations, which is 
consistent with earlier studies.
H.pylori infection is present in a large number of 
healthy individuals. Only a proportion of them, 
however, go on to develop duodenal ulceration. This 
may be related to a variable elevation in plasma 
gastrin concentration produced by H.pylori in 
different individuals. The basal and meal stimulated 
plasma gastrin concentrations in H.pylori positive and 
negative asymptomatic volunteers were compared with 
corresponding values in H .pylori positive duodenal 
ulcer patients. The H.pylori positive asymptomatic 
volunteers and the H.pylori positive duodenal ulcer 
patients showed no difference in their basal or meal 
stimulated plasma gastrin concentrations and these 
values were higher than the corresponding values in 
H.pylori negative asymptomatic volunteers. This 
suggested that other factors in addition to elevated
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plasma gastrin may be responsible for the 
predisposition to duodenal ulceration in patients with 
H.pylori positive duodenal ulcers.
The mechanism by which chronic H.pylori infection 
of the gastric antrum elevates plasma gastrin 
concentrations is not clear. It may be due to 
elevation of antral surface pH or direct stimulation of 
gastrin release by the ammonium produced as a result of 
the bacterium's urease activity. The antral gastritis 
induced by the infection may increase gastrin release 
by the G cells or the hypergastrinaemia may be a 
physiological response to inhibition of parietal cell 
function by H.pylori
The effect of increasing H.pylori ammonium 
production by urea infusion on plasma gastrin
concentrations in duodenal ulcer patients was studied. 
Despite a greater than three fold increase in bacterial 
ammonium production there was no change in plasma 
gastrin concentrations. This did not support the 
hypergastrinaemia being due to local ammonium
production. It, however, did not exclude this 
possibility as the amount of ammonia produced by 
H.pylori under normal conditions may be sufficient to 
produce maximum gastrin response by this mechanism.
To further elucidate this, Triple therapy
(amoxycillin, metronidazole and tripotassium dicitrato
X IV
bismuthate) was used to suppress H.pylori urease 
activity in duodenal ulcer subjects to that seen in
H.pylori negative individuals. Despite this profound 
suppression in bacterial urease activity there was no 
change in basal or meal stimulated plasma gastrin 
concentrations. This confirms that the 
hypergastrinaemia in H.pylori infection is not a direct 
result of ammonia production by bacterial urease 
activity or via elevation of elevation of antral 
surface pH. It was also noted that the acute 
inflammatory cell component of the antral gastritis 
resolved rapidly after commencement of H.pylori 
eradication therapy and was not associated with a fall 
in plasma gastrin concentration.
If H.pylori induced hypergastrinaemia were due to 
elevation of antral surface pH the difference in plasma 
gastrin concentration between H.pylori positive and 
eradicated patients would largely or completely 
disappear at neutral pH. In addition, antral 
alkalinisation which results in an increase in meal 
stimulated gastrin response, would produce less of an 
increase in the integrated gastrin response to a meal 
in H.pylori positive than in H .pylori eradicated 
patients. There was, however, a persistent difference 
in plasma gastrin concentrations between H.pylori 
positive and eradicated patients even at neutral pH.
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The integrated gastrin response to a meal rose to a 
similar degree in the presence and absence of H.pylori 
infection. Both these findings exclude H.pylori 
induced hypergastrinaemia being due to elevation of 
antral surface pH.
H.pylori induced hypergastrinaemia may be a 
physiological response to inhibition of parietal cell 
function by the organism. The parietal cell 
sensitivity to pentagastrin before and after 
eradication of H.pylori was examined in duodenal ulcer 
subjects by determining the acid output to graduated 
doses of pentagastrin. There was no difference in 
parietal cell sensitivity to pentagastrin following 
eradication of H.pylori. This finding does not support 
the hypergastrinaemia being due to diminished parietal 
cell sensitivity in the presence of H.pylori 
infection.
These studies have demonstrated that chronic
H.pylori infection induces hypergastrinaemia. Some of 
the possible mechanisms by which this can be brought 
about have been examined and excluded. Other possible 
mechanisms are via the chronic gastritis induced by the 
infection. It is also possible that the elevated 
plasma gastrin concentrations consist of forms of 
gastrin that are immunoreactive but not functionally 
active. Further research is needed to elucidate this.
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SECTION I
INTRODUCTION AND BACKGROUND
CHAPTER 1
HELICOBACTER PYLORI
1.1 INTRODUCTION
The discovery of Helicobacter pylori ( H.pylori ) 
has revolutionised thinking about duodenal ulcer 
disease. Although its presence in gastric biopsies had 
been noted for many years the significance of this 
infection was not realised until it was first cultured 
in 1983 ( WARREN et al 1983 ) . Then it was called
Campylobacter pyloridis and has since undergone two 
changes in its name. Initially to Campylobacter pylori 
and in 1989 to its present name, Helicobacter pylori 
(GOODWIN et al 1989).
The organism is mainly confined to the gastric 
epithelium of the antrum and body of the stomach. In 
addition, areas of gastric metaplasia anywhere along 
the gastrointestinal tract can be infected ( PAULL et 
al 1988, WYATT et al 1987, CASELLI et al 1988 ). It, 
however, does not infect areas of intestinal metaplasia 
in the stomach ( MEYRICK-THOMAS 1984 ) . It is an
extracellular organism and is found in the gastric pits 
and on the luminal surface of the epithelial cells.
1.2 STRUCTURE
H.pylori is a sinusoidal Gram negative bacillus 
(Fig 1). It is 2-6.5 microns long by 0.5-0.6 microns 
wide. Its surface is smooth and has 4-6 unipolar 
sheathed flagellae which have a terminal bulb. There is
1
Figure 1 Photomicrograph of H.pylori
also a coccoid form which may be the organism's attempt 
at adapting to a hostile environment (BODE et al 1988) . 
Only the sinusoidal form, however, is found in vivo.
1.3 ENZYMES
H.pylori is rich in a number of enzymes. The 
urease enzyme, however, is the one that has attracted 
the most attention. The activity of this enzyme in
H . pylori is greater than that seen in any other 
bacteria ( MOBLEY et al 1988 ) . The enzyme has a
molecular weight of 625,000 +/- 15,000 Daltons, pHi of 
5.9, Km of 0.8 mmol of urea, an optimal temperature of 
45 degrees C and optimal pH of 8.2 ( MOBLEY et al 
1988 ) . It has a narrow substrate specificity and 
hydrolyses urea to produce ammonium and bicarbonate 
(BLAKELEY et al 1969, GORIN 1959). Elevated
concentrations of ammonia, however, do not seem to have 
a feed back inhibitory effect on urease synthesis 
(FERRERO et al 1988) . In addition to urease, H.pvlori 
also possess superoxide dismutase, catalase and lipase.
1.4 EPIDEMIOLOGY
The prevalence of H.pvlori infection differs 
worldwide. There seems to be higher prevalence in the 
underdeveloped countries than in the developed ones, 
with a 15-25% prevalence in the general population of
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the USA, Western Europe, Australia and New Zealand and 
60-70% prevalence amongst Chinese and Tongans (GRAHAM 
et al 1988, MORRIS et al 1986, LANGENBERG et al 1984, 
BARTHEL et al 1988, BERKOWICZ et al 1987). The 
prevalence of the infection increases with age. Few 
children harbour the infection, whereas in the 60-84 
age group over 82% of people are infected (GRAHAM et al 
1988). This high prevalence of infection throws doubt 
on what is now accepted as gastric physiology, as many 
of the subjects in these studies were probably infected 
with the organism.
1.5 NATURAL HISTORY
Ingestion of H.pylori results in acute onset of 
dyspeptic symptoms associated with acute gastritis 
(MARSHALL et al 1985, MORRIS A. et al 1987) . In some 
this is followed by resolution of the infection and 
gastritis ( MARSHALL et al 198 5 ) but in others the 
organism persists with development of chronic gastritis 
( MORRIS et al 1987 ) . Once established, the infection 
does not clear spontaneously. Amongst individuals in 
whom the infection persists, most remain asymptomatic 
but some go on to develop signs and symptoms of 
duodenal ulceration. The reason for only some of the 
individuals with the infection developing ulceration is 
not clear.
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1.6 TRANSMISSION OF INFECTION
The mechanism of spread of this organism is not 
known. Evidence from various studies suggests that 
there is a person to person spread. An Australian 
study done in an institution where infections with 
person to person spread have higher incidence found 
that, in younger people, H.pylori infection was higher 
in the residents of the institution than in a control 
group and in each age group a higher proportion showed 
presence of the infection ( BERKOWICZ et al 1987 ). It 
has also been shown that there is increased prevalence 
of the infection in family members of cases of H.pylori 
than in the general population ( MITCHELL et al 1987 ) 
Studies done on abattoir workers and veterinarians 
show an increased prevalence of H.pylori in these 
occupational groups suggesting that animals may be an 
important reservoir of H.pylori ( MORRIS et al 1986, 
VAIRA et al 1988 ). The infection is probably acquired 
by ingestion of the organisms as was shown in 
volunteers who swallowed a culture of H.pylori and in 
subjects undergoing repeated gastric secretory studies 
( RAMSEY et al 1979, MORRIS et al 1987, GRAHAM et al 
1988 ) as well as endoscopy staff ( MORRIS et al 1986, 
RAWLES et al 1987 ).
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1.7 ROLE IN GASTRITIS
ACUTE GASTRITIS
In acute infection with H.pylori , as occurred 
following ingestion of cultures of H.pylori , there is 
an acute gastritis. The antral mucosa shows 
infiltration by large numbers of polymorphonuclear 
leucocytes and the antral mucosal surface becomes 
irregular. The organism can be seen in the gastric 
mucus close to the epithelial cells lining the mucosal 
surface and gastric pits ( MARSHALL et al 1985, MORRIS 
et al 1987, GRAHAM et al 1988 ).
CHRONIC GASTRITIS
Chronic gastritis can be classified into
Pathogenesis
- Type A
- Type B
- Type C
- Lymphocytic
- Eosinophilic
- Granulomatous
autoimmune 
bacteria associated 
chemical injury such as 
enterogastric reflux, 
Nonsteroidal anti­
inflammatory drugs, 
Alcohol
? hypersensitivity 
allergy
? hypersensitivity
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There is good evidence showing that chronic
H.pylori infection is the major cause of type B 
gastritis. This evidence comes from studies looking at 
the effect of ingestion of H.pylori r correlation 
between type B gastritis and H.pylori positivity and 
the effect of eradication of H.pylori on gastritis.
Ingestion of H.pylori results in an acute 
gastritis with a spontaneous resolution of the 
inflammation (MARSHALL et al 1985). In some, however, 
this is followed by chronic gastritis ( MORRIS et al
1987 ).
H.pylori infection is seen in 86-100% of subjects 
with chronic type B gastritis ( MARSHALL et al 1985, 
VAIRA et al 1988, RATHBONE et al 1986, ANDERSEN et al 
1987, TYTGAT et al 1985, RAUWS et al 1988 ) and is
uncommon in subjects with normal gastric mucosa (TYTGAT 
et al 1985, RAUWS et al 1988). Eradication of the 
infection results in resolution of the gastritis (RAUWS 
et al 1988, MARSHALL et al 1987, McNULTY et al 1986). 
In those in whom the infection persists the severity of 
the gastritis, however, remains unchanged ( RAUWS et al
1988 ). Patients in whom there is clearance but not 
eradication of the infection, the gastritis shows 
improvement and with relapse of the infection the 
gastritis increases ( RAUWS et al 1988 ). In chronic
6
infection of the gastric antrum, there is an 
intraepithelial and interstitial neutrophil polymorph 
infiltrate in addition to lymphocytes and plasma cells. 
There may be loss of continuity in the epithelial cell 
lining resulting in erosions. The inflammation is 
predominantly in the antrum but in some, the body is 
involved as well. ANDERSEN et al ( 1987 ) showed a 
spatial relation between the polymorph infiltrate and 
the position of the H.pylori . This, however, was not 
confirmed by THOMSEN et al (1990) who were also unable 
to demonstrate any correlation between the polymorph 
infiltrate and density of infection. The epithelial 
cells show changes with infection. There is loss of 
microvilli, depletion of mucin content and cellular 
oedema ( THOMSEN et al 1990, MARSHALL et al 1985, CHEN 
et al 1986 ).
In chronic H.pylori infection the bacteria are 
seen in the mucus layer in the crypts and on the 
luminal surface of gastric epithelial cells. They show 
preference for the upper portion of the gastric pits. 
It was initially thought that the organism had some 
predilection for the epithelial junctions which were 
believed to be a source of nutrients (CHEN et al 1986) 
but this has not been confirmed ( THOMSEN et al 1990 ).
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1.8 LOCAL AND SYSTEMIC IMMUNE RESPONSE
The immune response to the infection is directed 
against the surface of the organism including the body 
and flagella. The serum antibodies are mainly of the 
IgG and IgA class but rarely IgM ( BOOTH et al 1986, 
RATHBONE et al 1986 ) . The lack of a significant
elevation of the IgM titre may be because the H.pylori 
colonisation is long standing. This antibody response, 
however, is unable to eliminate the infection or 
prevent recrudescence after temporary clearance. The 
gastric juice, and tissue culture supernatants of 
duodenal and gastric biopsies from patients with
H.pylori infection have specific anti-H.pylori 
antibodies, but unlike the circulating antibodies they 
are of the IgA class though some IgM is also present 
(RATHBONE et al 1986). This antibody response is 
appropriate for elimination of bacteria from mucosal 
surfaces. There is also a cellular response with an 
increased number of T cells of both CD4 and CD8 
positive subsets. So there is an adequate humoral as 
well as cellular response but despite this the H.pylori 
infection persists. The reason for this is not clear.
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1.9 ROLE IN GASTRODUODENAL PATHOLOGY
1.9.1 ACUTE INFECTION
Experience on the effects of acute ingestion of 
H.pylori is from the human ingestion studies and from 
cases of spontaneous hypo/achlorhydria seen in subjects 
participating in gastric secretory studies ( MARSHALL 
et al 1985, GRAHAM et al 1988 ). The symptoms developed 
by these patients were varied and included epigastric 
fullness, halitosis, nausea, vomiting, early morning 
hunger, irritability and headaches. This was 
associated with an acute increase in gastric acid, 
pepsin and mucus output followed by a fall in both acid 
and pepsin output for varying lengths of time ( GRAHAM 
et al 1988, RAMSEY et al 1979 ) . Following this there 
is, in most people, a spontaneous recovery.
1.9.2 CHRONIC INFECTION
In most cases this is asymptomatic. In some 
patients it leads to duodenal ulceration with its 
associated symptoms and complications. Its role in the 
causation of gastric ulcer, non ulcer dyspepsia and 
gastric cancer is less clear.
H.pylori AND DUODENAL ULCER
The association between this infection and
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duodenal ulceration is strong. It is seen in over 95% 
of those with duodenal ulcer ( 0 1 CONNOR et al 1986, 
RAUWS et al 1988 ) . In races which have a low
incidence of duodenal ulcer, such as the Aborigines 
from Northern Australia, the infection is seen in less 
than 1%. In the Aborigines who live in urban and 
semi-urban conditions, however, duodenal ulceration is 
seen more commonly and is associated with an infection 
rate of 50% ( BATESON 1976, DWYER et al 1988 ).
Eradication of the infection results in a fall in the 
ulcer relapse rate to 20-27% whereas in patients, not 
eradicated of H.pylori , the ulcer relapse rate is 
74-88% (COGHLAN et al 1987, SMITH et al 1988, LAMBERT 
et al 1987, BORODY et al 1988, GOODWIN et al 1988, 
MARSHALL 1988).
The mechanism by which H.pylori predisposes to 
duodenal ulceration is not clear but may be via 
increase in gastrin release from the G cells. Gastrin 
is trophic to parietal cells and is a strong stimulus 
to gastric acid secretion. So elevated plasma gastrin 
may increase gastric acid output. An increased acid 
output in patients with H.pylori infection would be 
consistent with earlier studies which showed a higher 
mean rate of gastric acid secretion in duodenal ulcer 
disease than in normal individuals (ISENBERG et al 
1975, PETERSEN et al 1975). This increased gastric
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acid output could induce gastric metaplasia in the 
duodenum. This metaplasia is thought to represent a 
response to injury to the duodenal mucosa due to an 
increased acid load. This is supported by studies in 
man which have shown that gastric metaplasia in the 
duodenum only occurs when the fasting intragastric pH 
is low and it correlates with maximal acid output 
(JAMES 1964, PATRICK et al 1974). It is extensive in 
patients with the Zollinger Ellison syndrome ( PARRISH 
et al 1965 ) . In low acid output states such as
atrophic gastritis, gastric metaplasia is not seen and 
its prevalence is lower in patients who have undergone 
highly selective vagotomy ( WYATT et al 1987 ).
H.pylori only infect gastric epithelium, 
therefore areas of gastric metaplasia in the duodenum 
may be infected by spread from the gastric antrum. 
Once the infection establishes in these areas of 
metaplasia it may have a local cytopathic effect 
resulting in reduced mucosal resistance. The organism 
also elaborates a lipase and protease which may weaken 
the mucus barrier. Incubation of gastric mucus with a 
filtrate of H.pylori has been shown to result in a 35% 
reduction in its viscosity ( SAROSIEK et al 1988 ) . 
These changes may reduce the mucosal resistance to 
gastric acid and pepsin resulting in erosions and 
ulceration.
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If the infection produced ulceration by weakening 
the mucus barrier, one would expect these ulcers to be 
more common in the antrum where the infection is seen 
more often and the pH is lower. This, however, is not 
the case. To explain this discrepancy it has been 
postulated that in the gastric antrum the organism, 
which is motile, moves along the epithelial surface 
allowing repair of the damaged mucus layer to occur. 
So there is a continuous cycle of damage and repair. 
In the areas of gastric metaplasia in the duodenum, 
however, the mobility may be restricted as H.pylori 
cannot infect normal duodenal epithelium. So there is 
no opportunity for repair of the damaged mucus layer 
resulting in progression to erosions and ulceration.
H.pylori AND GASTRIC ULCER
Chronic H.pylori infection of the gastric antrum 
is seen in about 70% of patients with gastric ulcer 
(MARSHALL et al 1984, O'CONNOR et al 1987). The
association of the infection with gastric ulcer,
therefore, is less strong than with duodenal
ulceration. However, it is possible that this is due
to inclusion of nonsteroidal anti-inflammatory drug 
induced ulcers in these studies.
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H.pylori AND GASTRIC CANCER
The prevalence of H.pylori in gastric cancer 
patients varies between 20-70% ( FENG et al 1988, JIANG 
et al 1987, RATHBONE et al 1988, LAMBERT et al 1985, 
GILMAN et al 1987, CHENG et al 1987 ). The organism, 
however, does not infect gastric cancer cells ( JIANG 
et al 1987 ).
Chronic gastritis is commonly seen with gastric 
carcinoma (MORSON 1955) and its presence may be used as 
an indicator of risk of gastric cancer ( CORREA 1983, 
SIURALA et al 1966 ) . H.pylori is by far the most 
common cause of chronic gastritis and it is possible 
that this infection predisposes to the development of 
gastric cancer. The prevalence of H.pylori infection 
is greater in patients with gastric cancer than in 
healthy controls but patients with colorectal cancer 
have a similar prevalence ( TALLEY et al 1990 ).
The role, if any, of H.pylori in development of 
gastric cancer is not clear and further work needs to 
be done before any pathogenic role can be attributed to 
Htpylpri .
H.pylori AND NON ULCER DYSPEPSIA
Nonulcer dyspepsia is defined as upper abdominal 
or retrosternal pain, discomfort, heartburn, nausea, 
vomiting or other symptoms considered to be referable
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to the proximal alimentary tract and lasting for more 
than 4 weeks, unrelated to exercise and for which no 
focal lesion or systemic disease can be found 
responsible. H.pylori infection is seen in 50% of 
patients with nonulcer dyspepsia ( MARSHALL et al 1984, 
BLOMBERG et al 1988). The association between H.pylori 
and non ulcer dyspepsia, however, is not clear because 
of the high frequency of colonisation with H. pylori in 
individuals without peptic ulceration. In addition, 
studies done so far have used different definitions for 
this condition.
In order to show that there is a link between 
nonulcer dyspepsia and H.pylori one would have to 
prove that there is an increased prevalence of H.pylori 
in this condition than controls and secondly treatment 
should produce a significantly greater improvement in 
symptoms in those eradicated of H.pylori than in those 
in whom the infection persists.
Many studies have looked at the prevalence of 
H.pylori in nonulcer dyspepsia. In 292 blood donors, 
never diagnosed to have peptic ulcer,the prevalence of 
H.pylori in subjects with dyspepsia was twice that of 
the rest ( MARSHALL 1988 ). RAUWS ( 1988 ) showed a 
significantly higher prevalence of H.pylori in 
nonulcer dyspepsia subjects than controls. The 
controls in this study were, however, 18 years younger.
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In a study on 247 blood donors, however, the occurrence 
of previous investigation for dyspepsia was associated 
with H.pylori infection only in those aged over 40 
years (WYATT et al 1988) . In 64% of those with 
positive serology there was no history of clinically 
significant dyspepsia. So there is at present no good 
evidence for a higher prevalence of H.pylori infection 
in subjects with nonulcer dyspepsia than in controls.
If the infection caused symptoms of nonulcer 
dyspepsia, eradication of it should improve these 
symptoms. In a group of patients with nonulcer 
dyspepsia, improvement in symptoms occurred in those 
eradicated of H.pylori , however, a similar improvement 
was seen in the noneradicated group ( McNULTY et al 
.1986 ) . There was no association between resolution of 
gastritis following treatment and resolution of 
symptoms. Others have done studies addressing the same 
problem but none have convincingly demonstrated an 
improvement in symptoms following eradication of the 
infection ( BORODY et al 1987, HOLCOMBE et al 1991 ). 
H.pylori does not appear to be major factor in the 
pathogenesis of nonulcer dyspepsia. There is
therefore, at present, no indication for eradication of
H.pylori in nonulcer dyspepsia except within the 
confines of a clinical trial.
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1.10 DIAGNOSIS
Infection with H.pylori can be diagnosed
by various methods.
(1) Microscopy
(2) Rapid Urease tests
(3) 13/14C-urea breath test
(4) Urea concentration in gastric juice
(5) Serology
(6) Culture
(1) Microscopy
Gastric antral biopsies collected during endoscopy 
can be used to determine H.pvlori status of an 
individual. The biopsies are usually stained with 
Giemsa or haematoxylin and eosin stain. With chronic 
infection, there is a chronic active gastritis i.e. 
there is a neutrophil polymorph infiltrate in the 
epithelium as well as the lamina propria in addition to 
the chronic inflammatory infiltrate (Fig 3) . The 
inflammation is maximal in the antrum but the body may 
be involved to a variable extent. Eradication of the 
infection results in an improvement in this gastritis.
RAUWS ( 1988 ) developed a scoring system for the 
activity of the gastritis. In this system, the density 
of the chronic inflammatory infiltrate in the lamina 
propria is given a score of 0-2, polymorphonuclear
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leucocytes in the lamina propria 0-3, intraepithelial 
polymorphonuclear leucocytes 0-3 and superficial 
erosions 0-2. For each parameter, 0 is none, 1 is 
mild, 2 is moderate and 3 is severe.
(2) Rapid urease tests
These tests utilise the organism's high urease 
activity to detect its presence. They only detect 
presence of preformed enzyme as further production is 
inhibited by addition of a bacteriostatic agent. In 
one test a modified urea broth is used and in the 
other, which is commonly used clinically, a 
commercially prepared slide (CLO test) is used. This 
CLO test slide has a dimple which contains a gel 
pellet. This pellet contains urea, phenol red and a 
bacteriostatic agent. The gel is buffered to an acid 
pH at which it has a bright yellow colour. An antral 
biopsy taken during endoscopy is put in the gel and the 
slide incubated at body temperature. In the presence 
of H.pvlori the urea is hydrolysed to ammonium and 
bicarbonate resulting in elevation of the pH of the gel 
( Fig 2 ).
urease
NH2.CO.NH2 + 2H20 + H+ ------> 2NH4 + HC03
urea ammonium bicarbonate
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Figure 2 CLO test. Top is a positive test and bottom is 
a negative-test.
Figure 3 H.pylori induced chronic active gastritis.
This produces a change in the colour of the phenol 
red from the bright yellow to red. A positive test is 
the development of a red colour within 24 hours.
Urease tests are simple and have a specificity of 
near 100% and sensitivity of at least 98% ( MARSHALL et 
al 1987 ). The sensitivity is however lower when it is 
used in specimens obtained from patients who have 
received treatment with antibiotics or bismuth.
(3) 13/14C-urea breath tests
This diagnostic test also relies on detecting the 
organism's high urease activity. It is a noninvasive, 
inexpensive and reproducible test to determine H.pylori 
status.
The patients present themselves after an overnight 
fast when they are given 250mls of Ensure Plus followed 
immediately by 0.4Mbq of 14C urea ( Amersham 
International ) in 2 0 mis of water. The Ensure Plus, 
which is a fatty meal, is given to delay gastric 
emptying of the 14C urea. Breath samples are collected 
before and at 10 minute intervals after ingestion of 
the 14C urea, for 2 hours. In the presence of H.pylori 
the 14C urea is hydrolysed to release 14C carbon 
dioxide which is exhaled. By measuring the 14C 
activity in the exhaled carbon dioxide using a 
scintillation beta counter one can determine the
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presence or absence of H.pylori. The results are 
expressed in % 14C dose per mmol C02 X 100 X Kg body 
weight. The 20 minute value has been shown to be most 
discriminating with a value of >40 confirming presence 
of H.pylori ( BELL et al 1987 ). Treatment with H2 
antagonists does not effect this test but antibiotic 
therapy is likely to influence it ( WEIL et al 1989 ) .
The radiation from this dose of 14C urea is less 
than that from a chest X-ray. It is better avoided in 
children and pregnant women. In these groups as well 
as in studies in which repeated assessments of H.pylori 
status are required a 13C urea breath test is better 
suited. The protocol for this test is similar to that 
for the 14C urea breath test except that the non 
radioactive isotope, 13C urea, is used instead of the 
radioactive 14C urea. The disadvantage, however, is 
that measurement of the 13C isotope requires a mass 
spectrometer which is not available at most hospitals.
(4) Urea concentration in gastric juice
The high urease activity of the organism 
hydrolyses the urea in gastric juice resulting in a 
fall in the urea and a rise in ammonium concentration 
in gastric juice. A urea concentration of less than 1 
mmol/1 in the gastric juice is indicative of infection 
with H.pylori . The ammonium concentration, however,
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is not as useful in determining H.pylori status. 
Determination of urea: ammonium ratio in aspirated
gastric juice has been shown to be superior to
measurement of urea or ammonium concentration alone in
H.pylori infection ( NEITHERCUT et al 1990 ) . This 
test may be used in patients who vomit, have
nasogastric tubes or in whom gastroscopy and /or 
gastric biopsy is contraindicated.
(5) Serology
Anti-H.pylori antibodies can be detected by 
various serological assays such as complement fixation, 
haemagglutination, bacterial agglutination and 
immunofluorescence but the enzyme linked immunosorbent 
assay ( ELISA ) is the test of choice. Serum IgA and 
G antibodies are elevated in infected individuals but 
the IgM antibody is not significantly different 
(RATHBONE et al 1986, STEER et al 1987). Following 
eradication of the infection the titres fall although
they may take a while to do so. So, elevated H.pylori
IgG antibody titres are not a good indicator of active 
infection with this organism.
(6) Culture
A variety of media, such as blood agar, chocolate 
agar and brain heart infusion agar, have been used to
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culture H.pylori from biopsies. For primary isolation 
both selective and nonselective media should be used. 
They are incubated in a microaerophilic atmosphere with 
an oxygen concentration of 5-7%. Growth is detected 
after 3-6 days of incubation. The advantage of 
culturing the organism is that its antibiotic 
sensitivity can be determined and it provides 
definitive proof of the presence of H.pylori .
1.11 TREATMENT
In determining efficacy of therapy, suppression of 
the organism has to be differentiated from eradication 
of the infection. Confirmation of absence of the
organism 4 weeks after completion of therapy is true
eradication. Tests done earlier can be used to show
persistence of the infection but not eradication.
Monotherapy using antibiotics or bismuth compounds 
have been shown to be relatively ineffective in 
eradicating the infection. Antibiotics though
effective in vitro are disappointing when used alone, 
in vivo. Trials using antibiotics such as
nitrofurantoin and amoxycillin achieve an eradication 
rate of 20% ( RAUWS et al 1988, GILMAN et al 1987 ). 
Various bismuth compounds have been used on their own 
to eradicate the organism. Bismuth subcitrate and 
subsalicylate have an eradication rate of 20-30%
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(LAMBERT et al 1987, BORSCH et al 1988). Combining the 
bismuth preparation with an antibiotic such as 
amoxycillin improves this to 40% ( RAUWS et al 1988, 
BAYERDORFFER et al 1987 ) but in a study using
tinidazole with bismuth subcitrate H .pylori was
eradicated in 75% of cases ( GOODWIN et al 1987 ).
Combining a bismuth compound with metronidazole 
and amoxycillin/tetracycline (triple therapy) improves 
the eradication rate to more than 9 0% ( BORODY et al 
1988, BORSCH et al 1988 ) . This is in contrast to the
poor eradication rates achieved when these drugs are
used individually.
The duration of therapy has been different in 
various studies. The long courses used initially are 
now felt to be unnecessary, with one and two week 
courses of triple therapy achieving as high an 
eradication rate as a 4 week course. The dosage of
Tripotassiura Dicitrato Bismuthate ( DeNol ) effects the 
therapeutic efficacy of this drug, with a dose of 120mg 
QID being more effective than 240mg BID.
The drugs used in the triple therapy are 
individually quite safe. Tripotassium dicitrato 
bismuthate causes darkening of the tongue and stool. 
Metronidazole can cause nausea, vomiting and a 
disulfiram like reaction with alcohol. Amoxycillin can 
cause loose stools and anaphylactic reaction in
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penicillin allergic individuals, in whom tetracycline 
may be used instead. The combination of three drugs 
carries a risk of drug hypersensitivity and antibiotic 
associated colitis.
The other problem with eradication of H.pylori is 
the emergence of metronidazole resistance. Different 
studies have shown the percentage of organisms 
resistant to metronidazole to vary between 6 to 27% 
(WEIL et al 1990, GLUPCZYNSKI et al 1990, BECX et al 
1990). This resistance may be due to treatment with 
this drug in the past, for other indications, ( WEIL et 
al 1990, BECX et al 1990 ) or may occur during the 
course of treatment, especially when nitroimidazoles 
are used as mono-therapy ( GOODWIN et al 1988, 
GLUPCZYNSKI et al 1987 ) . In view of this,
metronidazole should not be used as mono-therapy to 
eradicate H.pylori and unrestricted use of this drug 
for H.pylori infection should be discouraged.
The side effect profile and occurrence of 
metronidazole resistance in H.pylori suggest that 
eradication therapy should be prescribed only in the 
context of a research study and not for routine 
clinical use.
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CHAPTER 2
SERUM GASTRIN AND HELICOBACTER PYLORI
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2.1 INTRODUCTION
Gastrin was discovered by Edkins in 1905. The 
hormone is found in three main molecular forms - G-34 
or 'big gastrin1,G-17 or 'little gastrin' and G-14 or 
'mini-gastrin' . The amino acid composition of G-14 is 
identical to the carboxyl terminal tetradecapeptide of 
G-34 and G-17 and they share the same biological 
actions. They all occur in sulfated and non-sulfated 
forms.
There are, in addition, the carboxyl terminal 
glycine extended peptides corresponding to each 
molecular form of gastrin and the NH2 terminal 
tetradecapeptide fragment of gastrin-17, called 
(1-13)G17. These have different biological effects to 
the other gastrins and inhibit gastric acid secretion 
( PETERSEN et al 198 3 ). This, however, has not been 
confirmed in later studies ( HILSTED et al 1988, 
PAUWELS et al 1985 ) . Higher concentrations of glycine 
extended gastrin and (1-13)G17 have been reported in 
active duodenal ulcer disease but not when the ulcer is 
inactive.
2.2 SOURCE OF GASTRIN
Gastrin is secreted by the G cells which are 
mainly located in the antropyloric mucosa. Some G
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cells are also found in the proximal small intestine 
but are not present in the oxyntic mucosa, ileum or 
colon ( LARSSON et al 1977 ). In the stomach, they are 
found in the pyloric glands of the antrum and are most 
abundant in the mid portion of these glands. G cells 
have a flask shape with a broad base and a narrow neck. 
The microvilli on the mucosal surface of the G cell may 
contain receptors for stimulation and inhibition of by 
intragastric contents.
Somatostatin secreting D cells are found in very 
close relationship to the G cells. They have long 
cytoplasmic processes which come in contact with 
different glandular epithelial cells. Many of these 
processes end on G cells in the antropyloric mucosa and 
on parietal cells in the oxyntic mucosa ( LARSSON et al 
1979 ) . Somatostatin inhibits gastrin release under
basal conditions as well as following a meal 
(RAPTIS et al 1978) . The ratio of these two cells is 
controlled by antral pH; the G :D ratio increases in 
reduced acid secretory states and decreases in 
hypersecretory states ( ARNOLD 1982 ).
2.3 POTENCY OP GASTRIN
The carboxyl terminal tetrapeptide of the gastrin 
molecules has all the biological actions of the whole 
molecule. The G-17 and G-34 gastrins have equal
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potency for stimulation of acid secretion. Sulfated and 
non-sulfated forms are equipotent ( EYSSELEIN et al 
1984 ).
2.4 COMPOSITION OF PLASMA GASTRIN
In the fasting state, the molar ratio of G-34 to 
G-17 is about 2:1. After a meal the concentration of 
G-34 doubles but that of G-17 increases four times so 
that the ratio becomes 1:1 ( LAMERS et al 1979 ).
2.5 CATABOLISM
The half lives of G-17 and G-34 in the circulation 
are about 8 and 44 minutes ( WALSH et al 1976,EYSSELEIN 
et al 1984 ) . The half life of G-14 is similar to that 
of G-17 ( DEBAS et al 1974 ) . In pernicious anaemia
patients, the disappearance half time of plasma gastrin 
after antral acidification is 7 minutes ( YALOW et al 
1970 ).
The mechanism by which gastrin is rapidly cleared 
from the circulation is not clear. The liver plays a 
minor role in the catabolism of G-17 and G-34 (TRONBERG 
et al 1983, STRUNZ et al 1978) although it actively 
secretes pentagastrin into the bile (WYLLIE et al 
1974) . The kidney was thought to be the most important 
site of catabolism of gastrin as elevated plasma 
gastrin concentrations are seen in patients with renal
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failure ( DAVIDSON et al 1973 ) . The elevation of
gastrin concentrations is proportional to the 
glomerular filtration rate. Serum gastrin levels 
remain elevated in hemodialysed patients and are lower 
after renal transplantation ( HANSKY et al 1975, 
HALLGREN et al 1978, DOHERTY et al 1978, WESDORP et al 
1981 ) . The concentration of gastrin in the renal 
artery and vein during the basal state and during 
suppression of endogenous gastrin release by antral 
acidification are, however, not significantly different 
( BOOTH et al 1973 ) . Following endogenous release of 
gastrin the concentration of gastrin in the renal vein 
is 35% less than in the renal artery. This, however, 
was not associated with significant excretion of 
gastrin in urine ( BOOTH et al 1973 ). This fall in 
gastrin concentration across the renal circulation, 
however, does not differ significantly from the 
arterio-venous difference seen in the intestine, limb 
and head circulations ( STRUNZ et al 1978 ) . The
removal of circulatory gastrin, therefore, appears to 
occur at multiple sites and the kidney has no special 
role in its catabolism.
2.6 STIMULATION OF GASTRIN RELEASE
Gastrin release is stimulated by
- vagal excitation
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- gastric distention
- food stimulation
- blood borne chemical stimulation
VAGAL EXCITATION
In normal man, vagal excitation induced by 
modified sham feeding stimulates acid secretion (MAYER 
et al 1974, RICHARDSON et al 1977, FELDMAN et al 1979). 
The acid secretory response to sham feeding at an 
intragastric pH of 5, as measured by intragastric 
titration revealed a small rise in serum gastrin 
(RICHARDSON et al 1977, FELDMAN et al 1979) which, 
however, was not demonstrated in other studies which 
used direct gastric aspiration to measure gastric acid 
output ( MAYER et al 1974 ) . This rise in gastrin
concentration can explain only some of the acid 
response to sham feeding ( FELDMAN et al 1980 ) . Vagal 
stimulation of acid secretion is, therefore, probably 
brought about by gastrin release and direct cholinergic 
stimulation of parietal cells. It appears that gastrin 
release produced by vagal stimulation is mediated by 
gastrin releasing peptide ( DOCKRAY et al 1979 ).
SCHUBERT et al ( 1985 ) have demonstrated this by
abolishing vagally mediated gastrin release using 
specific bombesin antisera.
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GASTRIC DISTENTION
In dogs and pigs, distention of isolated antrum 
(DEBAS et al 1974, STADAAS et al 1974) and separated 
innervated fundus ( DEBAS 1974 ) stimulates gastrin 
release. This effect is probably mediated by local 
cholinergic reflexes as it can be blocked by atropine. 
A similar response to gastric distention could not, 
however, be demonstrated in humans ( SCHRUMPF et al 
1974 ). SOARES et al ( 1977 ), however, demonstrated 
a significant rise in gastrin at an intragastric 
pressure of 15cm H2 0.
FOOD STIMULATION
Proteins, peptones and amino acids stimulate 
gastrin release. Of the amino acids, phenylalanine and 
tryptophan are the most potent stimuli of gastrin 
release and acid secretion ( BYRNE 1977 ) . In
contrast, fat and glucose are weak stimulants of acid 
secretion and gastrin release ( RICHARDSON et al 1976, 
SAINT HILAIRE 1960 ) . Gastrin release is inhibited by 
restricting entry of amino acids into the gastrin cell, 
where as, it is stimulated by increase in intracellular 
amine levels ( LICHTENBERGER et al 1982, LICHTENBERGER 
et al 1986 ) .
The predominant increase in serum gastrin after 
meals is in the G-17 form. Using a G-17 antiserum,
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TAYLOR et al (1979) demonstrated that 50% of the 
postprandial gastrin was due to G-17.
CHEMICAL STIMULATION
Calcium stimulates gastrin release when given 
orally ( LEVANT et al 1973 ) or intravenously ( REEDER 
et al 1974 ) . Intravenous epinephrine produces a rise 
in plasma gastrin concentration ( STADIL et al 1973 ) 
but intense exercise, which releases endogenous 
epinephrine does not produce the same effect ( HOSTEIN 
et al 1978 ) suggesting that it does not have a role in 
gastrin release under physiological conditions. 
Bombesin, a peptide isolated from frog skin, is a 
potent stimulus of gastrin release.
2.7 INHIBITION OF GASTRIN RELEASE
The following have been shown to inhibit 
gastrin release
VAGAL EXCITATION
The vagus in addition to stimulating gastrin 
release also inhibits it. Atropine increases serum 
gastrin concentrations following insulin hypoglycaemia 
( FAROOQ et al 1975 ) and eaten meals ( KORMAN et al 
1971, WALSH et al 1971, BECKER et al 1974 ) and all 
forms of vagotomy result in a rise in basal gastrin
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concentrations ( KORMAN et al 1972, McGUIGAN et al 
1972, KRONBORG et al 1973, STERN et al 1973, JAFFE et 
al 1974 ). These studies suggest that the vagus has 
cholinergic fibres which inhibit gastrin release and 
when they are blocked by atropine, result in a rise in 
gastrin concentrations seen basally and following 
stimulation of the vagus. The rise in gastrin over 
preoperative levels is higher following selective 
proximal vagotomy than after truncal vagotomy ( LAM et 
al 1978 ) . This suggests that the vagal inhibitory 
pathways are located in the proximal stomach. This 
rise in gastrin is abolished by antrectomy implying 
that it arises from the antrum ( LAM et al 1978 ) . 
Other investigators have, however, been unable to 
demonstrate any change in basal gastrin with atropine 
( HANSKY et al 197 3, WALSH et al 1971, SCHRUMPF et al 
1974 ) .
GASTRIC ACIDITY
Gastrin release by the gastric antrum is inhibited 
by antral acidification ( WOODWARD et al 1960 ). There 
is a negative feedback control of gastrin release 
whereby gastrin stimulates acid secretion by the 
parietal cells and when the antral pH falls to about
1.5 there is inhibition of further gastrin release. 
Chronic achlorhydric states, such as pernicious
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anaemia, are associated with elevated levels of gastrin 
( PETERS et al 1983 ) . Intragastric instillation of 
hydrochloric acid in these patients results in a fall 
in gastrin in 5-15 minutes ( YALOW et al 1970 ). In 
addition, the gastrin response to a meal is 
inhibited by acidification ( WALSH 1975 ) . The
suppression of meal stimulated gastrin release by acid 
may be due to protonation of dietary amines, preventing 
their diffusion into the G cell and thereby their 
stimulation of gastrin release ( LICHTENBERGER et al 
1986 ).
The effect of antral alkalinisation, during 
fasting, on gastrin release is unclear. Some studies 
have shown no change ( LEVANT et al 197 3, HIGGS et al 
1974, KLINE et al 1975, FELDMAN et al 1978 ) while
others have shown a rise after 5 hours of antral 
alkalinisation ( PETERS et al 1983 ) .
CHEMICAL INHIBITION
A variety of gastrointestinal hormones inhibit 
gastrin release and its action on parietal cells. 
These include secretin ( THOMPSON et al 1972 ) ,
vasoactive intestinal polypeptide (RAYFORD et al 1974), 
Gastrin inhibitory polypeptide ( RAYFORD et al 1974 ) , 
glucagon ( BECKER et al 1975 ), somatostatin (RAPTIS et 
al 1978) and calcitonin ( BECKER et al 1974 ). Whether
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these effects have a physiological role is not clear. 
Somatostatin inhibits gastrin by paracrine action. 
Histological studies have demonstrated that cytoplasmic 
processes from mammalian somatostatin cells in the 
antrum make direct contact with gastrin cells ( LARSSON 
et al 1979, KUSUMOTO et al 1979 ). Intravenous
somatostatin inhibits release of gastrin from gastrin 
cells as well as the action of gastrin on parietal 
cells ( SCHRUMPF et al 1978 ) . Using antibodies
directed against somatostatin an increase in basal and 
stimulated gastrin release has been demonstrated in an 
isolated perfused stomach ( SHORT et al 1985 ).
2.8 ACTIONS OF GASTRIN
Gastrin has two major physiological effects on the 
stomach. Firstly, it stimulates the parietal cells to 
secrete acid and is the major stimulant of acid 
secretion after food ( FELDMAN et al 1978, RICHARDSON 
et al 1976 ).
It does this
- directly, by stimulating gastrin receptors on 
parietal cells. Activation of the gastrin receptor 
also potentiates histamine stimulated acid secretion.
- indirectly, by stimulating release of histamine 
from mast cells which then stimulates acid secretion.
Secondly, it stimulates division of stem cells
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within gastric oxyntic glands ( JOHNSON et al 1976 ). 
These cells in turn can differentiate into parietal 
cells, surface epithelial cells and enterochromaffin 
like cells.
Studies done to correlate gastrin with acid 
secretion between individuals resulted in controversial 
findings which may be due to variable parietal cell 
sensitivity to endogenous gastrin ( TRUDEAU et al 1971, 
GEDDE-DAHL 1975, PETERSEN et al 1975, WESDORP 1974 ). 
However, within individuals, there is correlation 
between serum gastrin concentrations and acid secretion 
( LAM et al 1979 ) . In addition, the maximal acid 
output is inversely related to post prandial integrated 
gastrin response ( LAM et al 1976 ) suggesting there is 
an inverse relationship between G cell mass and 
parietal cell mass.
Gastrin also stimulates pepsin secretion and 
increases gastric mucosal blood flow. Contraction of 
the lower oesophageal sphincter appears to occur only 
at supra-physiological concentrations of gastrin.
Postprandial levels of gastrin have been shown to 
stimulate gastric mucosal DNA synthesis (JOHNSON 1977) . 
Antrectomy results in mucosal atrophy in most of the 
gastrointestinal tract which can be prevented by 
exogenous gastrin administration ( SEIDEL et al 1985 ). 
This trophic effect of gastrin on gastric mucosa is
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antagonised by secretin and vasoactive intestinal 
polypeptide ( STANLEY et al 1972 ). A similar effect 
is seen with proglumide, an antagonist of gastrin that 
acts by competitively binding to gastrin receptors 
(JOHNSON et al 1984). Conditions associated with 
prolonged elevations of gastrin, as Zollinger Ellison 
syndrome, are associated with gastric mucosal 
hypertrophy. The trophic effect of gastrin on colonic 
mucosa, however, is not clear.
2.9 GASTRIN AND DUODENAL ULCERATION
There is evidence that gastrin may play a role in 
the pathogenesis of duodenal ulceration. Basal serum 
gastrin has been demonstrated to be elevated in 
duodenal ulcer patients when compared with controls 
(GEDDE-DAHL 1975). Other studies, however, have been 
unable to show any difference ( GANGULI et al 1972, 
McGUIGAN et al 1973, STADIL et al 1973 ). The
post-prandial gastrin response is also unclear, with 
some studies demonstrating a higher response in ulcer 
patients than controls ( McGUIGAN et al 1973, TAYLOR et 
al 1979, NYREN et al 1986 ) and others unable to
demonstrate any difference ( HUGHES et al 1976, LAM et 
al 1980, HIRSCHOWITZ et al 1985, BLAIR et al 1987 ). 
WALSH et al (1975) reported that the normal inhibition 
of gastrin release by a fall in intragastric pH is
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impaired in ulcer patients suggesting a defect in 
autoregulation. Maximal acid output, which reflects 
parietal cell mass, (CARD et al 1960, CHENG et al 1977) 
may be normal or elevated in duodenal ulcer patients 
(BARON et al 1973). The acid secretory response to a 
meal in duodenal ulcer patients, though not higher, is 
more prolonged than in controls ( BLAIR et al 1987 ). 
Ulcer patients are more sensitive than normals to the 
stimulation of acid secretion by pentagastrin (ISENBERG 
et al 1975) as well as endogenous gastrin ( LAM et al 
1980 ).
There have been conflicting reports concerning the 
concentration of gastrin in antral mucosa of duodenal 
ulcer patients compared with controls with studies 
showing higher, lower and no difference in 
concentration of gastrin in antral mucosa of ulcer 
patients ( MALMSTROM et al 1975, CREUTZFELDT et al 
1976, MALMSTROM 1976 ) . The G cell mass in ulcer 
patients was higher than controls but showed a wide 
variation (ROYSTON et al 1978).
It, therefore, appears that duodenal ulcer 
patients are a heterogeneous group with a wide range of 
parietal and gastrin cell masses.
2.10 OTHER CAUSES OF HYPERGASTRINAEMIA
Conditions in which elevated levels of plasma
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gastrin have a pathogenic role are Zollinger Ellison 
syndrome and isolated retained antrum syndrome. In 
addition, elevated levels of gastrin are seen in 
antral G cell hyperplasia ( POLAK et al 1972 ) , 
pyloric stenosis ( TANI et al 1977 ) , chronic renal 
failure (HANSKY et al 1975, HALLGREN et al 1978) 
intestinal resection ( STRAUS et al 1974 ), vagotomy 
(WALSH et al 1975, LAM et al 1978) and in atrophic 
gastritis with or without pernicious anaemia (TRUDEAU 
et al 1971, GANGULI et al 1971, STRICKLAND et al 1971).
2.11 PATHOGENESIS OF HYPERGASTRINAEMIA IN 
CHRONIC HELICOBACTER PYLORI INFECTION
H.pylori induced gastritis is predominantly in the 
antrum. Eradication of the infection results in a fall 
in both basal and meal stimulated plasma gastrin 
concentrations ( McCOLL et al 1991,ODERDA et al 1989 ) . 
The mechanism by which H.pylori raises plasma gastrin 
concentration is unclear. This may be brought about by
(1) Elevation of antral surface pH
H.pylori has a high urease activity by which it 
hydrolyses urea to produce ammonium and bicarbonate. 
The ammonium may raise antral surface pH resulting in 
loss of the physiological inhibition of gastrin release 
by luminal acid. This would result in increased release
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of gastrin from the G cells.
(2) Direct stimulation of gastrin release by bacterial 
ammonium
The ammonium produced by the organism may be a 
direct stimulus to gastrin release by the G cells. In 
rats,dietary ammonia produces an elevation in serum 
gastrin and this elevation is greater than that seen in 
controls ( LICHTENBERGER et al 1981 ).
(3) Inducing antral gastritis
Antral gastritis induced by the infection may 
increase gastrin release from the G cells. In a study 
on dyspeptic patients, the fasting serum gastrin in the 
group with H.pylori positive or negative gastritis was 
greater than that seen in the group with normal mucosa 
( WYATT et al 1989 ) . These findings suggest that
gastritis, independent of H.pylori status, results in 
raised serum gastrin. Immunohistochemical studies of 
gastric mucosal biopsy specimens with H.pylori- 
associated gastritis demonstrate the presence of an 
increased number of T cells ( ENGSTRAND et al 1989 ). 
TEICHMANN et al (1989) have shown that the T-cell 
products interleukin-2 and gamma-interferon induce 
gastrin release in isolated perfused canine antrum.
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(4) a physiological response to inhibition of parietal 
cell function by the infection
H.pylori may produce a factor which inhibits the 
parietal cells resulting in reduced gastric acid output 
and the hypergastrinaemia may be a physiological 
response to this.
BORODY et al ( 1989 ) studied the effect of
eradication of H.pylori with triple therapy in 14 
patients with H.pylori positive hypochlorhydria. On 
reassessment 8 weeks after commencement of therapy, the 
gastric pH showed a significant fall from a 
pretreatment value of 6.9 to 1.5 post-treatment. In the 
6, in whom the organism was not eradicated, the 
corresponding values were unchanged at 6.8 and 5.3 .
DEFIZE et al ( 1988 ) , in a study on isolated
guinea pig parietal cells showed a 50% inhibition of 
histamine stimulated acid production by H .pylori.
CAVE et al ( 1989 ) measured the effect of
H.pylori on 14C-aminopyrine uptake by rabbit gastric 
epithelial cells. There was a significant inhibition of 
acid secretion equivalent to that produced by 0.0001 
mol/1 of cimetidine. This occurred with whole organisms 
and sonicates and was not due to a toxic effect of the 
inhibitor on the epithelial cells.
All these studies suggest that the infection 
produces a factor that inhibits acid production by the
40
parietal cells.
H.pylori may raise serum gastrin by one or a 
combination of these mechanisms or by other still 
undiscovered means. The aim of this thesis is to 
determine which of these mechanisms is responsible for 
the hypergastrinaemia seen with chronic Helicobacter 
pylQri infection.
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SECTION II
EXPERIMENTAL WORK
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CHAPTER 3
THE DEGREE OF HYPERGASTRINAEMIA INDUCED 
HELICOBACTER PYLORI IS THE SAME IN DUODENAL 
PATIENTS AND ASYMPTOMATIC VOLUNTEERS
BY
ULCER
43
3.1 Introduction
There is considerable evidence that Helicobacter 
pylori infection of the gastric antrum predisposes to 
duodenal ulceration. The mechanism by which the 
H.pylori predisposes to duodenal ulceration is unclear 
but may be related to the excessive release of gastrin 
by the inflamed antral mucosa. Eradication of H.pylori 
results in a 27-33% fall in basal plasma gastrin and a 
30-58% fall in the integrated gastrin response to a 
meal.
H.pylori infection is also found in a considerable 
proportion of the healthy non-ulcer population and its 
prevalence increases with age. In asymptomatic 
Caucasian individuals the organism is present in 
approximately 10% of those under 20 years of age 
compared with 70% of those more than 8 0 years old 
(GRAHAM et al 1988) . There has been no direct 
comparison of the effect of H.pylori infection on 
gastrin in duodenal ulcer patients versus asymptomatic 
volunteers. The relative effect of H.pylori on serum 
gastrin in these groups should indicate the importance 
of the hypergastrinaemia in the pathogenesis of the 
ulcer disease.
I have examined basal and meal stimulated gastrin 
concentrations in H.pylori positive and negative 
healthy volunteers and compared these with values in
44
duodenal ulcer patients.
3.2 Patients
Eleven duodenal ulcer patients ( mean age 41 
years, one woman ) in whom active duodenal ulceration 
within the previous year had been confirmed
endoscopically, were studied. H.pylori infection had 
been confirmed in each patient by 14C-urea breath test, 
rapid urease test ( CLO test, Delta West Ltd, Bentley, 
Western Australia ) and antral histology performed 
within the previous month. Acid inhibitory agents were 
discontinued at least 2 weeks before entry into the 
study. None had received any bismuth preparations.
Eleven asymptomatic volunteers with H.pylori 
infection ( mean age 4 0 years, all men ) and 11 
asymptomatic volunteers without H .pylori infection 
(mean aged 37 years, one woman) were also examined. 
Their H.pylori status had been confirmed by either the 
14C- (n=10) or 13C- (n=12) urea breath test.
The 14C-urea breath test was performed as 
previously described and the 20-min value used as this 
has been shown to be the most discriminating ( BELL et 
1 al 1987 ). The mean 20-min value (%14C dose per mmol 
C02 X 100 X body weight (kg)) of the four volunteers to 
be positive with this test was 160 (range 108-227) and 
the values for those negative was 5 (range 4-7). For
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the 13C-urea breath test, the volunteers were given 
250ml Ensure Plus (Abbot laboratories, Maidenhead, UK) 
to delay gastric emptying, immediately followed by O.lg 
of 13C-urea in 50ml of water. Breath samples were 
collected before and at 4 0 and 60 min after 
administration of the isotope for 13C02 analysis. A 
rise in the breath 13C02 over the baseline, of more 
than five parts per 1000 was taken as a positive 
result. The mean rise in breath 13C02 (parts per 1000) 
in the five volunteers considered negative for H.pylori 
was 1.35 ( range 0.31-3.66 ) and that in those positive 
was 15.85 ( range 10.08-28.00 ). The 13C-urea breath 
test has been shown to be an accurate means of 
determining H.pylori status ( DILL et al 1990 ).
3.3 Materials and Methods
Basal plasma gastrin and the integrated gastrin 
response to a standardised meal was measured in all the 
patients and volunteers. They presented one morning 
after an overnight fast. Blood samples were collected 
at 15-min intervals for 3 0 minutes for determination of 
basal plasma gastrin. They then drank, over 5 minutes, 
a standardised peptone meal consisting of two OXO beef 
cubes ( 0X0 Ltd., Croydon, UK ) in 200ml of water at 50 
degrees C. A blood sample was collected 5 minutes 
after completing the drink and further samples at
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10-minute intervals for 90 minutes, for gastrin 
determination.
Blood samples for plasma gastrin estimation were 
collected and analysed as described before. Samples 
from duodenal ulcer patients and healthy volunteers 
were assayed in the same batch. The basal gastrin 
value was taken as the mean of the three samples taken 
prior to the meal.
Statistical significance was assessed by the Mann 
Whitney U test. The study was approved by the Western 
Infirmary Ethical Committee and each patient gave 
written informed consent.
3.4 Results
The median basal plasma gastrin in the H.pylori 
positive volunteers was 47ng/l ( range 27-95 ) and was 
not different from that in the duodenal ulcer patients 
with H.pylori infection ( 53ng/l, 13-103 )( p=0.4 ).
The median basal gastrin in the H.pylori negative 
volunteers was 20ng/l ( range 7-45 ) which was lower 
than the H.pylori positive volunteers ( p<0.001 ) and 
duodenal ulcer patients ( p<0.002 ) ( Fig 4, Table 1 ).
The median integrated gastrin response to the meal 
was also similar in the H.pylori positive volunteers 
and duodenal ulcer patients with respective values of 
2650 ng/l.min (range 900-8500) and 2225 ng/l.min (range
47
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550-8725)( p=0.7 ). The integrated gastrin response in 
the H.pylori negative volunteers was 550 ng/l.min 
(range 225-2925) which was less than that in the 
H.pylori positive volunteers ( p<0.001 ) and duodenal 
ulcer patients ( p<0.002 ) ( Fig 5, Table 1 ).
More detailed analysis was performed to 
investigate any possible difference between the gastrin 
response in the H.pylori positive duodenal ulcer 
patients and H.pvlori positive volunteers. This showed 
that there was no difference between these groups with 
respect to the gastrin values at any of the 12 time 
points studied. In addition there was no difference in 
the time for gastrin to return to its basal value 
following the meal in the two groups ( Fig 6 ).
3.5 Discussion
There is a strong association between H.pvlori 
infection and duodenal ulceration ( O'CONNOR et al 
1986, RAUWS et al 1988 ). However, the infection is 
found in approximately 50% of adults in the Western 
world ( GRAHAM et al 1991 ) whereas duodenal ulceration 
affects only about 10% of this population ( LANGMAN 
1979 ) . The reason for less than one in five people 
with H.pvlori infection developing duodenal ulceration 
is not clear. The present study investigated the 
possibility that the likelihood of developing duodenal
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ulceration may be related to the degree of 
hypergastrinaemia induced by the chronic infection.
The results demonstrate that H.pylori infection 
raises plasma gastrin concentrations in healthy 
volunteers as well as duodenal ulcer patients. My study 
also demonstrates that basal and meal stimulated 
gastrin concentrations in the H.pylori positive 
volunteers were not different from those in H.pylori 
positive duodenal ulcer patients. This finding 
indicates that the explanation for only the minority of 
the population with H.pylori infection developing 
duodenal ulceration is not the degree of 
hypergastrinaemia induced by the infection.
In conclusion, the finding that H.pylori raises 
plasma gastrin to a similar level in duodenal ulcer 
patients and asymptomatic volunteers indicates that 
factors other than hypergastrinaemia must play a role 
in the pathogenesis of ulcer disease.
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CHAPTER 4
EFFECT OF INCREASING HELICOBACTER PYLORI AMMONIA 
PRODUCTION BY UREA INFUSION ON PLASMA GASTRIN
CONCENTRATIONS
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4.1 INTRODUCTION
Patients with Helicobacter pylori infection of the 
gastric antrum have raised plasm gastrin concentrations 
(LEVI et al 1989) which fall when the infection has 
been eradicated ( CHAPTER 5, ODERDA et al 1989 ).
Gastrin may be the link between chronic H.pylori 
infection and duodenal ulceration ( LEVI et al 
1989). The mechanism by which H.pylori infection 
increases the plasma gastrin concentration is unknown 
but could be related to its high urease activity 
( MARSHALL et al 1986 ) . The ammonia produced by the 
bacterial urease could directly stimulate gastrin 
release by G cells or indirectly by raising antral 
surface pH.
To determine whether the raised plasma 
gastrin concentrations is the result of ammonia 
production by H.pylori I studied the effect of 
altering the rate of ammonia formation on plasma 
gastrin concentration by infusing urea 
intragastrically.
4.2 PATIENTS
Eight patients ( five men ) with a history of 
endoscopically confirmed duodenal ulceration within the 
previous year were studied. Their ages ranged from 
26 to 62 years. Each of the patients had H.pylori
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infection of the gastric antrum confirmed by histology 
of antral biopsy specimens, rapid urease test ( CLO 
test ) (MARSHALL et al 1987) and 14C urea breath test ( 
BELL et al 1987 ) . None had taken any acid inhibitory 
agents or bismuth preparations in the month before the 
study.
4.3 METHODS
The plasma gastrin response to increasing H.pylori 
ammonia production was investigated by infusing a urea 
solution into the gastric antrum. Each patient acted 
as his or her own control by having the urea infusion 
repeated one month after a 3 week course of 
tripotassium dicitrato bismuthate ( De-Noltab ) 120mg 
QID and metronidazole 400mg TID designed to eradicate 
H.pylori. Confirmation of eradication of H.pylori was 
achieved by repeating the endoscopic antral biopsies 
and 14C urea breath test one month after the completion 
of treatment.
After a 16 hour fast a dual lumen size 16 F 
gastric tube (Andersen Inc, New York) was passed 
nasogastrically and positioned radiographically so that 
its tip lay in the distal part of the stomach. An 
intravenous cannula was inserted in the antecubital 
vein. At the end of a 3 0 minute basal period the 
stomach was emptied, and over the following hour
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dextrose solution ( 328 mmol/1 ) that did not contain 
urea was infused into the stomach at a rate of 2 ml per 
minute. After this control period, a dextrose
solution containing urea ( 50 mmol/1 ) was infused at 
a rate of 2 ml per minute for four hours. The 
concentration of dextrose in the urea solution was 
reduced by 50 mmol/1 so that the osmolalities of the 
two infusions were the same. In addition, the pH of 
the solutions was reduced to 1.8 by adding 1 ml 
concentrated HC1 per 500 ml dextrose to prevent them 
raising intragastric pH.
Venous blood samples were obtained at 30 minute 
intervals throughout the experiment for plasma gastrin 
determination and were collected in lithium heparin 
tubes containing 4000 KIU aprotonin ( Trasylol ). The 
blood was centrifuged at 3000g for 10 minutes at 4 
degrees C. and the plasma was stored at -2 0 degrees C.
During the intragastric infusions, 10 ml samples of 
gastric juice were collected every 15 minutes for 
measurement of the ammonium and urea concentration and 
determination of pH. At the end of each hour all the 
gastric contents were aspirated to prevent the 
accumulation of infusate.
The plasma gastrin concentration was measured 
by radioimmunoassay using antibody R98 which has a 
lower limit of detection of 5-10 ng/1 ( ARDILL 1973 ).
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Gastric aspirate urea concentrations were measured by 
a urease method ( SMAC I Technicon, Basingstoke, UK ) 
and ammonium concentrations by an enzymatic method 
(SIGMA, Dorset, UK) . The pH of the gastric aspirate 
was measured with a glass electrode (Radiometer ETS 
822) .
Statistical significance was assessed by Wilcoxon 
signed rank sum test. The study was approved by the 
Western Infirmary Ethical committee and each patient 
gave informed written consent.
4.4 RESULTS
In seven patients the H.pylori infection was 
successfully eradicated as confirmed by the absence of 
organisms and resolution of gastritis seen on antral 
biopsy specimens, negative CLO test and negative 14C 
urea breath test four weeks after completing the 
antibacterial treatment. Their median 20 minute breath 
test value was 135% of administered dose per mmol C02 
X kg body weight X 100 ( range 104-251 ) before
treatment and fell to 4.5 ( range 0.6-7) one month
afterwards. The one patient in whom the organism 
was not cleared was excluded from further analysis.
BASAL VALUES
The median concentration of ammonium ions in the
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basal gastric aspirate before eradication of H.pylori 
was 4.4 mmol/1 ( range 1.8-14.7 ) and this fell after 
eradication to 0.7 mmol/1 ( range 0.3-1.4 ) (p<0.02).
The median concentration of urea in the basal gastric 
aspirate was 1.1 mmol/1 ( range 0.3- 1.6 ) and rose to
2.5 mmol/1 ( range 1.0-3.4 ) after eradication
(p<0.02). The median plasma concentration of gastrin 
was 30 ng/1 ( range 15-60 ) and this fell to 20ng/l 
(range 15-25) (p<0.05) after eradication. The median
pH of the basal gastric aspirates did not change 
significantly - it was pH 1.7 ( range 1.2-1.9 ) before 
and 1.6 ( range 1.2-1.7 ) after eradication of H.pylori 
( Fig 7, Tables 2,3,4,5 ).
EFFECT OF INTRAGASTRIC INFUSIONS
During the 60 minute control infusion of dextrose 
solution, both before and after eradication, there was 
a progressive fall in urea and ammonium concentrations 
in the gastric aspirate due to dilution by the 
infusate. Plasma gastrin concentration did not change 
over this period.
Before eradication of H.pylori, the urea infusion 
resulted in a rise in the gastric aspirate urea 
concentrations which reached a plateau after 60 minutes 
at a median value of 15.5 mmol/1 ( range 7.9-21.3 ). 
The median gastric juice ammonium concentration
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Figure 7 Gastric juice concentrations of urea 
(mmol/1) and ammonium (mmol/1) and plasma 
gastrin concentrations (ng/1) before and after 
eradication of H ♦pylori infe c t i o n  in 7 
duodenal ulcer subjects.
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Figure 8 Effect of intragastric infusion of * urea on 
gastric juice concentrations of urea(mmol/1) and 
ammonium(mmol/1) , intragastric pH and plasma gastrin 
concentration(ng/1) in 7 patients with H .pylori infection 
of the gastric antrum. Values are medians.
40
Gastrin
(ng/L)
20
HH4
(mmol/1)
0
20
Urea 
(mmol/1)
10 1
DEXTROSE UREA + DEXTROSE
PH
0 1 2 3 4 5
TIME (hours)
Figure 9 Effect of intragastric infusion oft urea on 
gastric juice concentrations of urea (mmol/1) and ammonium 
(mmol/1), intragastric pH and plasma gastrin concentration 
(ng/1) in 7 patients following eradication of H .pylori 
infection of the gastric antrum. Values are medians.
immediately before beginning the urea infusion was 2.3 
mmol/1 ( range 1 . 3 - 5 . 9 ) and rose over 90 minutes to 
reach a median plateau value of 6.1 mmol/1 ( range 4.2- 
11.9 ). This rise in ammonium production was not
accompanied by any change in plasma gastrin 
concentration (Fig 8, Tables 2,3,4,5 ).
After eradication of H.pylorir the rise in gastric 
juice urea concentration during urea infusion was 
similar to that before eradication. On this occasion, 
however, there was no rise in the ammonium
concentration. The median value immediately before 
beginning the infusion was 0.4 mmol/1 ( range
0.1-0.9 ) and it was 0.4 mmol/1 ( range 0.3-1.2 ) at 
the end of the infusion. The median gastrin 
concentration, which was lower after eradication of 
H.pylorif was unaffected by the urea infusion ( Fig 9, 
Tables 2,3,4,5 ).
The pH of gastric aspirates remained between 1.5 
and 2.0 throughout the studies ( Fig 8,9 ).
4.5 DISCUSSION
In agreement with work done by McCOLL et al 
(1989), this study demonstrated a considerable lowering 
of plasma gastrin concentrations after eradication of 
H.pylori infection in duodenal ulcer subjects. The 
finding that increasing H.pylori ammonia production
56
failed to change the plasma gastrin concentration does 
not lend support to the hypothesis that the 
hypergastrinaemia is caused by the ammonia. It seems 
unlikely that the degree of increase in ammonia 
production was inadequate as the rise in the ammonium 
ion concentration at the antral epithelial surface, 
where the bacteria are found close to the gastrin 
secreting G cells, would have been greater than the 
three fold rise noted in the gastric aspirate. It 
should be stressed, however, that the failure to cause 
a further increase in gastrin by augmenting ammonia 
production does not exclude the possibility that the 
raised gastrin value was caused by the organism's 
ammonia production. The amount of ammonia produced by 
the bacterium under normal conditions may be sufficient 
to produce the maximum gastrin response via this 
mechanism.
It has been proposed by LEVI et al ( 1989 ) 
that the increased plasma gastrin concentrations are 
caused by the organism's ammonia production raising 
antral surface pH. This would interfere with the 
physiological suppression of gastrin release by luminal 
acid. Our finding that augmenting H.pylori ammonia 
production fails to stimulate gastrin does not refute 
this hypothesis. The local alkalinising effect of 
H.pylori under basal conditions may already be
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sufficient to prevent suppression of gastrin release by 
gastric acid. In addition, the duration of the urea 
infusion in our study was four hours and earlier 
studies have shown that gastric alkalinisation was 
required for five hours before there was any rise in 
serum gastrin ( PETERS et al 1983 ) . The effect of 
antral alkalinisation on serum gastrin in humans is 
controversial, however, as a more recent study could 
not detect any increase after raising gastric pH for 10 
hours ( PETERSON et al 1986 ). Unfortunately, there are 
no studies of the effect of gastric alkalinisation on 
serum gastrin in patients of known H.pylori status.
In conclusion, though lowering intragastric 
ammonia concentration by eradicating H.pylori is 
accompanied by a lowering of plasma gastrin 
concentration, augmenting the bacterium*s ammonia 
production is not accompanied by a further increase in 
plasma gastrin.
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CHAPTER 5
EFFECT OF COMPLETE SUPPRESSION OF H.PYLORI UREASE 
ACTIVITY ON SERUM GASTRIN
59
5.1 INTRODUCTION
The mechanism by which the chronic antral H.pylori 
infection predisposes to duodenal ulceration is unclear 
but stimulation of excessive gastrin release may be 
important ( ODERDA et al 1989, LEVI et al 1989, GRAHAM 
et al 1990 ) . Eradication of H.pylori infection
results in a fall in the basal gastrin concentration of 
27-33% and a fall of 30-58% in the integrated gastrin 
response to a meal. The mechanism by which H.pylori 
infection raises plasma gastrin concentration is 
unclear and may be related to the organism*s high 
urease activity or the antral gastritis induced by the 
infection.
In an attempt to differentiate between the effects 
of the H.pylori urease activity and the antral 
gastritis I decided to examine serum gastrin 
concentrations soon after commencing H.pylori 
eradication therapy. At this early time I hoped to 
achieve complete suppression of bacterial urease 
activity without significant resolution of the antral 
gastritis.
5.2 PATIENTS
Ten patients ( 7 male,age range 31-65 ) with a 
history of endoscopically confirmed duodenal ulcer were 
studied. In each of the patients H.pylori infection
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had been demonstrated by histology of antral biopsy and 
rapid urease test ( CLO test ) ( MARSHALL et al 1987 ).
All the patients discontinued any therapy with acid 
inhibitory agents for at least two weeks before 
entering the study. During this period they were 
allowed antacids except for the 24 hours preceding the 
first study day. None had taken bismuth preparations 
previously.
Four volunteers who were shown to be negative for 
H.pylori by a 14C-urea breath test served as a control 
group.
5.3 MATERIALS AND METHODS
In 8 of the patients the following studies were 
conducted. Following a 14C-urea breath test to 
determine H.pylori urease activity, upper 
gastrointestinal endoscopy was performed and two antral 
biopsies taken for assessment of severity of antral 
gastritis. Within 3 weeks following this the patients 
reported fasted one morning and two samples of venous 
blood were collected 15 minutes apart for estimation of 
basal serum gastrin concentration. They then drank 
over 5 minutes, 250mls of Ensure Plus (Abott 
laboratories, England) which contains 12.5g fat, 15.6g 
protein and 50g carbohydrate. The gastrin response to 
this was measured by taking serum samples at 5 minutes
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after completing the drink and then at 10 minute 
intervals for 9 0 minutes.
On the morning after completing the above tests 
they commenced tripotassium dicitrato bismuthate 
(De-Nol) 120mg qid, amoxycillin 500mg tid and 
metronidazole 4 00mg tid ( Triple therapy ). They took 
one complete day's treatment and reported fasted the 
following morning. Their morning dose of therapy was 
administered at 08:00h and one hour later two samples 
of blood were obtained 15 minutes apart for estimation 
of basal serum gastrin. Immediately following this a 
14C-urea breath test was performed. The breath test 
involves drinking 2 50mls of Ensure Plus to delay 
gastric emptying of the 14C urea. It was therefore 
possible to simultaneously reassess the gastrin 
response to this. Studies have shown that a fall in 
meal stimulated gastrin response following eradication 
of H.pylori occurs with various meals ( GRAHAM et al 
1990, LEVI et al 1989 ) and is not specific to the 0X0 
meal. At 13:00 hours an upper gastrointestinal 
endoscopy was repeated and further antral biopsies 
obtained for a CLO test and to reassess the severity of 
the gastritis. The four hour delay between the breath 
test and endoscopy was to allow gastric emptying of the 
Ensure Plus. The patients then went on to complete the 
3 week course of triple therapy. One month after
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completion of therapy their H.pylori status was 
reassessed by 14C-urea breath test, antral histology 
and CLO test.
The other two patients were studied in a similar 
fashion except that their gastrin response to a 
standardised 0X0 meal ( 0X0 LtdCroydon, England ) was 
assessed immediately prior to performing the 14C-urea 
breath test. This prolonged the second study day and 
meant that upper gastrointestinal endoscopy could not 
be performed. The response to the 0X0 meal was 
undertaken as the original observation of a marked fall 
in integrated gastrin response following eradication of 
H.pylori used this meal. The standardised 0X0 meal 
was prepared by dissolving 2 0X0 cubes in 200mls of 
water at 50 degrees Centigrade. They drank this over 5 
minutes. The first sample of serum for gastrin 
estimation was collected 5 minutes after completion of 
the meal and further samples at 10 minute intervals for 
90 minutes.
The 4 healthy volunteers without H.pylori 
infection served as the control group. They had their 
gastrin response to a standardised 0X0 meal measured 
before and 24 hours after commencement on the same 
triple therapy regimen as the patient group.
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5.4 ANALYSES
The blood samples for estimation of plasma gastrin 
were collected and assayed as previously described. 
All samples for each patient were measured in the same 
assay.
The antral biopsies were stained with haematoxylin 
and eosin stain and examined double blind by a single 
pathologist and given an aggregate gastritis score of 
between 1-10 as described by RAUWS ( 1988 ) . Chronic 
inflammatory infiltrate in the lamina propria was 
scored as 0-2, lamina propria polymorph infiltrate as 
0-3, intra-epithelial polymorph infiltrate as 0-3 and 
mucosal erosions as 0-2.
Statistical significance was assessed by Wilcoxon 
signed rank sum test. The study was approved by the 
Western Infirmary Ethical Committee and each patient 
gave informed written consent.
5.5 RESULTS
The 24 hours of triple therapy produced profound 
suppression of H.pylori urease activity. The breath 
test 2 0 minute reading ( %14C dose per mmol C02 X 100 
X Kg body weight ) fell from a median pretreatment 
value of 176 (range 116-504) to 5 ( range 2-15
) (p<0.005) ( Fig 10, Table 6 ) . The CLO test which was 
positive at 5 hours in all patients pretreatment, was
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negative at >24 hours when repeated 28 hours after 
commencement on triple therapy. There was also
evidence of some resolution of the gastritis within 
this period. The median pretreatment aggregate antral 
gastritis score in the 8 patients studied was 6 ( range 
4-6 ) compared with 3 ( range 2-5 ) after 28 hours
therapy ( P<0.02 ). The change was mainly in the
polymorph infiltrate in the epithelium and lamina 
propria with little change in the chronic inflammatory 
infiltrate in the lamina propria. The sum of the
scores of the polymorph infiltrate in the epithelium 
and the lamina propria fell from a median pretreatment 
value of 4 ( range 3-4 ) to 1 ( range 1-3 ) after 28 
hours therapy ( p<0.02 ). The score of the chronic
inflammatory infiltrate in the lamina propria remained 
unchanged at 2 ( range 1-2 )( Fig 13, Table 7 ).
Despite profound suppression of urease activity 
and significant reduction in the severity of the 
polymorphonuclear infiltrate in the antral mucosa 
neither the basal nor the meal stimulated serum gastrin 
concentrations were altered. The median pretreatment 
basal gastrin concentration of the 10 patients was 7 
ng/1 ( range 45-77 ) compared with 59ng/l (range 45-80) 
after 24 hours of triple therapy ( Fig 11, Table 6 ). 
The median pretreatment integrated gastrin response to 
the Ensure Plus meal in the 8 patients was 4265
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Figure 13
Change in antral gastritis 28 hours after commencement 
on triple therapy. The columns represent the median 
value of 8 patients and the error bars, the range
(I/Su) 
uijcqs^o ernsexd
ng/l.min ( range 1975-8350 ) and after 24 hours of 
triple therapy was 4272 ng/l.min ( range 2075-6495 ) 
(Fig 12, Table 6) . The integrated gastrin response to 
the OXO meal was also unchanged in the 2 patients 
studied, their pretreatment values being 5455 and 1760 
ng/l.min and after 24 hours triple therapy were 5070 
and 1595 ng/l.min, respectively ( Fig 14 ).
Of the 10 patients, 6 were eradicated of H.pylori 
when reassessed one month following completion of 
triple therapy.
In the 4 healthy volunteers without H.pylori 
infection there was no change in the integrated gastrin 
response to an 0X0 meal after 24 hours of triple 
therapy. Their mean pretreatment value was 4500 
ng/l.min ( range 2000-6000 ) and after 24 hours therapy 
was 3760ng/l.min ( range 2000-6500 ).
5.6 DISCUSSION
It has been postulated that the hypergastrinaemia 
associated with chronic H.pylori infection is secondary 
to the production of ammonia by the organism close to 
the antral epithelial cell surface ( LEVI et al 1989 ). 
In this study the triple therapy produced complete 
suppression of the bacterial urease activity. This is 
not surprising as bismuth has been shown to be a 
powerful inhibitor of H.pylori urease activity as well
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as being bactericidal ( SAROSIEK et al 1990 ) . Our 
observation that this degree of suppression of 
H.pylori urease activity did not result in a fall in 
basal serum gastrin or meal stimulated gastrin response 
does not support the hypergastrinaemia being directly 
related to the bacterial urease activity. If the 
hypergastrinaemia were due to elevation of antral 
surface pH by bacterial ammonia, the hormone level 
should fall rapidly following suppression of ammonia 
production and thereby fall in antral surface pH. In 
patients with grossly elevated gastrin concentrations 
due to achlorhydria, intragastric instillation of 
hydrochloric acid causes the plasma gastrin to fall 
within 5-15 minutes ( YALLOW et al 1970 ).
It is now necessary to consider alternative 
explanations for the hypergastrinaemia. It is possible 
that it is related to the effects on the antral G cells 
of the chronic inflammation that H.pylori infection 
induces in the antral mucosa. At 28 hours after 
commencing anti-H.pylori therapy there was already 
early resolution of the antral gastritis but no change 
in the gastrin concentration. The change in the 
gastritis score, however, only affected the degree of 
infiltration of the epithelium and lamina propria with 
polymorphonuclear cells and there was no change in the 
chronic inflammatory infiltrate. It has been shown in
67
isolated perfused canine antrum that the T lymphocyte 
products, Interleukin-2 and Gamma Interferon, stimulate 
gastrin release ( TEICHMANN et al 1986 ) . It is
possible that resolution of the chronic inflammatory 
infiltrate is required before a change in the plasma 
gastrin concentration can be observed.
In conclusion, this study indicates that the 
hypergastrinaemia in patients with H.pylori infection 
is not directly linked to the bacterial urease activity 
and ammonia production. It also highlights the rapid 
rate of resolution of the acute inflammatory cell 
component of the antral gastritis following 
commencement of anti-H.pylori therapy.
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CHAPTER 6
HELICOBACTER PYLORI RELATED HYPERGASTRINAEMIA IS NOT 
DUE TO ELEVATION OF ANTRAL SURFACE pH BY THE 
ORGANISM'S UREASE ACTIVITY
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6.1 INTRODUCTION
It is well established that acidification of 
the gastric antrum suppresses the release of gastrin 
both basally and in response to eating ( BEFRITS et al 
1984, WALSH et al 1975, FELDMAN et al 1980 ). However, 
the effect of acute alkalinisation of the antrum on 
gastrin release is less clear, with some studies 
showing increased release of the hormone ( PETERS et 
al 1983, HANSKY et al 1971 ) but others no change ( 
SVENSSON et al 1979, PETERSEN et al 1986, LEVANT et al 
1973, HIGGS et al 1974, KLINE et al 1975, FELDMAN et al 
1978 ) . The reason for these conflicting findings is 
unknown.
Eradication of H.pylori results in a lowering of 
both the basal and meal stimulated serum gastrin 
concentration ( ODERDA et al 1989, LEVI et al 1989, 
GRAHAM et al 1990 ) . It has been proposed that the 
ammonia produced by the bacterium's urease raises 
antral surface pH and thus stimulates gastrin release 
( LEVI et al 1989 ) . If H.pylori infection does effect 
gastrin release via an effect on antral pH, the 
conflicting reports concerning the gastrin response to 
acute alkalinisation might be explained by differing 
H.pylori status of the groups studied.
I have investigated the influence of H.pylori
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infection on the gastrin response to antral 
alkalinisation under both basal and meal stimulated 
conditions in duodenal ulcer patients.
6.2 PATIENTS
Eight patients ( 7 male, age range 32-60 years ) 
with endoscopically confirmed duodenal ulceration 
within the previous year were entered into the study. 
Infection with H.pylori was confirmed by a rapid urease 
slide test (CLO test) histology of antral biopsy and 
14C-urea breath test. All patients were off acid 
inhibitory agents for at least two weeks before entry 
into the study.
6.3 MATERIALS AND METHODS
In each patient, the gastrin response to a 
standardised meal at uncontrolled pH and at pH>6 was 
compared before and after eradication of H.pylori. In 
six of them the gastrin response to 5 hours of antral 
alkalinisation was also studied before and after 
eradication of H.pylori.
On the first morning, the gastrin response 
to a standardised peptone meal was measured. The 
meal was prepared by dissolving 2 0X0 cubes ( 0X0 Ltd., 
Croydon, England ) in 2 00 mis of water at 50 degrees 
Centigrade and was drunk over 5 minutes. Three venous 
blood samples were obtained at 15 minute intervals
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prior to the meal. A further venous blood sample was 
collected 5 minutes after completion of the meal and at 
10 minute intervals after that for 90 minutes.
On a second morning, within a week of the above 
test, the effect of gastric alkalinisation on the 
gastrin response to the standardised meal was assessed. 
A 16F dual lumen tube was passed orogastrically 
(Andersen Inc.,New York), the stomach emptied and a 
sample of gastric juice stored for measurement of pH. 
A sample of venous blood was collected for 
determination of basal plasma gastrin. Further samples 
of gastric juice and venous blood were collected at 15 
minute intervals over the next 30 minutes. At the end 
of this period the stomach was emptied and an 
intragastric infusion of pH 7 citrate buffer
(530mmol/l) was commenced at a rate of 6 mls/min. 
One hour after commencement of the infusion the peptone 
meal was taken over 5 minutes. The infusion was 
continued for a further 90 minutes and 20ml samples of
gastric juice collected every 20 minutes for pH
determination with a glass electrode ( Radiometer ETS 
822 ). Venous blood samples were collected as described 
above for gastrin determination.
In 7 of the 8 patients the plasma gastrin
response to gastric alkalinisation alone was 
assessed. An orogastric tube was passed and basal
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gastric juice and venous blood samples collected as 
described above. After this an intragastric infusion of 
pH 7 citrate buffer ( 53 0mmol/l ) was commenced at a 
rate of 4mls/min. and continued for 5 hours. 
Throughout this time samples of blood were collected 
every hour and gastric juice every 3 0 minutes for 
measurement of plasma gastrin and pH. The stomach was 
emptied at the end of each hour to prevent distention.
Following the above studies, the patients were 
commenced on a three week course of H.pylori 
eradication therapy consisting of Tripotassium 
Dicitrato Bismuthate 120mg QID, Metronidazole 400mg TID 
and Amoxycillin 500mg TID. One month after completion 
of therapy their H.pylori status was reassessed by CLO 
test, antral histology and 14C-urea breath test. After 
this the plasma gastrin response to the standardised 
peptone meal with and without gastric alkalinisation 
and to gastric alkalinisation alone was reassessed.
Blood samples were collected for determination of 
plasma gastrin concentration were collected and assayed 
as previously described. All the samples from a patient 
were assayed in the same batch.
Statistical significance was assessed by the 
Wilcoxon signed rank sum test. The study was approved 
by the Western Infirmary Ethical Committee and each 
patient gave informed written consent.
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6.4 RESULTS
All patients were eradicated of H.pylori when 
reassessed one month after completion of the triple 
therapy. The 14C-urea breath test 20 minute value fell 
from a median pretreatment value of 12 6 (range 55-26) 
to 4 ( range 2-8 ) one month after completion of
therapy. The CLO test which was positive at <5 hours 
pretreatment was still negative at 24 hours when 
repeated at one month post-treatment.
The basal plasma gastrin assessed on the day the 
peptone meal was given without alkalinisation, fell 
from a median pretreatment value of 57ng/l ( range 
20-103 ) to 42ng/l (range 18-80)(p<0.05) following
eradication of H .pylori (Fig 16(a)). The median 
integrated gastrin response to the peptone meal without 
alkalinisation was 2525ng/l.min. ( range 550-8725 )
pretreatment and fell to 725ng/l.min.(range 250-2925) 
following eradication ( p<0.01 )( Fig 16(a), Table 9 ). 
On the day the meal was given with alkalinisation the 
infusion of citrate buffer raised the intragastric pH 
to >6 within 30 minutes and this was maintained for 
the duration of the study. The median integrated 
gastrin response to the peptone meal with gastric 
alkalinisation was 3700ng/l.min.( range 1900- 14100 ) 
pretreatment and fell to 1400ng/l.min.(range 400-3400) 
one month after completion of therapy ( p<0.01 ) ( Fig
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16(b), Table 9).
Alkalinisation of the stomach resulted in a rise 
in the integrated gastrin response to the peptone meal 
in 6 of the 8 patients both before and after 
eradication of H.pylori. The median % change in the 8 
patients was +73% ( range -63 to +500 ) pretreatment 
which was similar to that seen after eradication of 
the infection, median +48% ( range -19 to +386% ) ( NS, 
p=0.9 )( Table 9 ).
After eradication of H.pylori, the median fall in 
the integrated gastrin response to the peptone meal 
alone was 69% (range 36-89) and was similar to that 
seen with the peptone meal plus gastric alkalinisation, 
61% ( range 0-97 ) ( Fig 16 ).
On the day that the effect of gastric 
alkalinisation without a meal was studied there was a 
rise in the plasma gastrin concentration in 6 of the 7 
patients before and in the same number after 
eradication of H .pylori. The others did not show any 
change in the plasma gastrin with alkalinisation. The 
median plasma gastrin concentration after 5 hours of 
alkalinisation was greater before, ( 65ng/l, range
48-185 ), than after, ( 40ng/l, range 25-82 ),
eradication of H.pylori (p<0.02). The percentage change 
in gastrin with alkalinisation alone was similar before 
(median = 13%, range -4 to 225) and after (median=25%,
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range 0-94) eradication of H.pylori ( NS,p=0.2 ) 
(Table 8).
6.5 DISCUSSION
There are conflicting reports concerning the
effect of alkalinisation of the antrum, during fasting, 
on gastrin release in man. Several studies have 
reported that acute elevation of antral pH does not 
alter the serum gastrin concentration ( LEVANT et al 
1973, HIGGS et al 1974, KLINE et al 1975, FELDMAN et al 
1978 ) . However, PETERS et al (1983) noted that
maintaining antral pH above 6 for 5 hours produced an 
increase in serum gastrin. HANSKY et al (1971) also 
reported an increase in serum gastrin in both duodenal 
ulcer subjects and healthy volunteers which was 
apparent within 30 minutes of alkalinisation. These 
conflicting studies were all conducted before H.pylori 
infection was recognised and its effect on gastrin 
release appreciated.
In this study we have shown that the fall in 
gastrin is equally pronounced when the intragastric pH 
is maintained above 6. When the peptone meal is taken 
without alkalinisation the buffering effect of the meal 
raises the intragastric pH above 2 for less than 15 
minutes ( McCOLL et al 1991 ) It has been postulated 
that H.pylori raises plasma gastrin by its ammonia
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production blocking the inhibitory effect of gastric 
acid on gastrin release ( LEVI et al 1989 ). If this 
were true, the difference in plasma gastrin 
concentrations between H.pylori positive and eradicated 
patients would largely or completely disappear when 
examined at neutral pH. Our finding that the difference 
remained the same at neutral pH indicates that H.pylori 
induced hypergastrinaemia is not due to elevation of 
antral surface pH.
Alkalinisation of the antrum has an immediate 
effect on the meal stimulated gastrin response ( WALSH 
et al 1975 ) and this is consistent with the finding 
that the gastrin response to the meal was increased by 
alkalinisation. The finding that alkalinisation of the 
antrum increased the meal stimulated gastrin response 
to a similar degree in the presence and absence of 
H.pylori again excludes H.pylori induced 
hypergastrinaemia being due to elevation of antral 
surface pH. The reason for two of the subjects not 
showing increased gastrin response to alkalinisation 
either before or after eradication of H.pylori is 
unclear.
Our studies of the effect of alkalinisation 
without a meal also showed a similar response before 
and after eradication of H .pylori. If basal gastrin 
concentration were raised due to elevation of antral
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surface pH by H.pylorif raising intragastric pH should 
produce less of a rise in plasma gastrin concentration 
before than after eradication of H.pylori and the 
plasma gastrin level achieved after 5 hours of 
alkalinisation should be similar on both occasions. 
However, we, found that the % change in the plasma 
gastrin with alkalinisation was similar in the presence 
or absence of H.pylori and the gastrin levels achieved 
after 5 hours remained higher in the H . pylori positive 
group.
The findings of the present study confirm that 
H.pylori induced hypergastrinaemia is not due to 
elevated antral surface pH.
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CHAPTER 7
EFFECT OF HELICOBACTER PYLORI ON PARIETAL CELL 
SENSITIVITY TO PENTAGASTRIN IN DUODENAL ULCER
SUBJECTS
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7.1 INTRODUCTION
Numerous studies have demonstrated that chronic 
H.pylori infection results in raised basal and meal 
stimulated plasma gastrin concentrations which fall 
after eradication of the organism ( McCOLL et al 1991, 
ODERDA et al 1989, LEVI et al 1989,GRAHAM et al 1990 ). 
The mechanism by which the infection raises these 
gastrin concentrations is unknown but does not appear 
to be related to the organism's high urease activity 
( El NUJUMI et al 1991., CHAPTER 8,9 ).
The role of the hypergastrinaemia in the 
pathogenesis of the ulcer disease is also unclear as 
lowering the gastrin level by eradicating H.pylori does 
not reduce basal or maximal acid output ( LEVI et al 
1989 ) . Meal stimulated acid output is also unchanged 
after eradication of H.pylori ( FULLARTON et al 1991 ) 
even though gastrin is the main determinant of meal 
stimulated secretion ( KOVACS et al 1989 ) .
Inappropriately high gastrin values relative to 
intragastric acidity also occurs in healthy volunteers 
with H.pylori infection. SMITH et al ( 1990 ) noted 
that the integrated 24h gastrin concentrations in 
H.pylori positive volunteers was twice that in H.pylori 
negative volunteers but there was no difference in 
integrated 24 hour intragastric acidity between the two
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groups. The same group noted that eradication of 
H.pylori in healthy volunteers lowered the gastrin 
concentration but did not alter intragastric acidity 
( PREWETT et al 1991 ). PETERSON et al ( 1991 ) noted 
that healthy volunteers with H.pylori had increased 
basal and meal stimulated gastrin concentrations 
compared with uninfected volunteers yet there was no 
difference between the two groups with regard to basal, 
maximal or meal stimulated acid outputs. The reason 
for the inappropriately high gastrin concentrations for 
the degree of acid secretion in the presence of 
H.pylori infection is unknown.
When H.pylori is first contracted it may produce 
a period of hypochlorhydria which persists for several 
months ( GRAHAM et al 1988 ). In addition in vitro 
studies have demonstrated that the organism produces a 
substance that specifically inhibits parietal cell 
function ( DEFIZE et al 1988, CAVE et al 1989 ). It is 
possible that some inhibition of parietal cell function 
persists during chronic H.pylori infection and that the 
hypergastrinaemia represents a compensatory response to 
re-establish normal acid secretion.
To investigate this I examined the effect of 
eradicating H.pylori on the parietal cell sensitivity 
to pentagastrin in duodenal ulcer patients.
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7.2 PATIENTS
Eight patients ( 6 male ) with a history of
endoscopically confirmed duodenal ulceration within the 
previous year were entered into the study. Their 
median age was 45 years ( range 33-63 ) and median 
weight 71kg ( range 58-80 ). None of them had active 
ulceration at the time of the study. H.pylori infection 
was confirmed in each patient by each of the following 
three tests - microscopy of the antral biopsy specimen, 
the rapid urease test (CLO test) and the 14C-urea 
breath test. Acid inhibitory agents were withdrawn for 
at least 2 weeks before the first study day. None had 
previously been treated with bismuth preparations.
7.3 MATERIALS AND METHODS
Gastric acid output in response to increasing 
doses of intravenous pentagastrin was determined before 
and after eradication of H.pylori . Basal plasma 
gastrin concentrations were also measured.
The patients presented at 0900h after an overnight 
fast. A 16F dual lumen tube (Andersen Inc., New York) 
was passed orogastrically, the stomach emptied and the 
positioning of the tube in the dependent portion of the 
stomach confirmed by the water recovery test. Two 15 
minute specimens of basal gastric juice were collected. 
An intravenous infusion of pentagastrin was then
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commenced at a rate of 0.03lug/kg/hour using an 
infusion pump ( Braun Medical Ltd., UK ) . The rate of 
the pentagastrin infusion was progressively increased 
at 45 minute intervals to 0.062, 0.124 and
0.6ug/kg/hour. Three 15 minute collections of gastric 
juice were obtained at each infusion rate.
A venous blood sample for gastrin determination 
was collected at the commencement of the gastric 
aspiration and at 15 minute intervals until 
commencement of the pentagastrin infusion.
After the above tests the patients received a 3 
week course of H.pylori eradication therapy consisting 
of tripotassium dicitratobismuthate ( DeNol ) , 12 0mg
four times daily; metronidazole, 400mg three times 
daily; and amoxycillin, 500mg three times daily. One 
month after completing this treatment, their H.pylori 
status was reassessed by microscopy of the antral 
biopsy specimen, the CLO test and the 14C-urea breath 
test and their secretory and gastrin studies were 
repeated.
7.4 ANALYSES
The volume and pH of each collection of gastric 
juice was recorded and the hydrogen ion concentration 
determined by titration with 0.1N sodium hydroxide to 
pH7 using an autotitrator ( Radiometer ETS 822 ). The
83
basal acid output ( mmol/h ) was calculated by 
multiplying by 2, the sum of the hydrogen ion output in 
the two basal 15 minute collections of gastric juice. 
The acid output of each pentagastrin dose ( mmol/h ) 
was the sum of the results of the second and third 15 
minute collection at each infusion rate multiplied by 
two.
Gastrin determination was performed by 
radioimmunoassay using antibody R98, as previously 
described ( ARDILL 1973 ). Basal gastrin was taken as 
the mean value of the 3 samples obtained prior to 
commencing the pentagastrin infusion.
Power calculations were performed assuming 
alpha=0.05, beta=0.2 and the tests were two-sided. 
Under such conditions it would be expected that with 
n=8 we could detect a difference equivalent to one 
standard deviation using a parametric test.
The study was approved by the Western Infirmary 
Ethical Committee and each patient gave informed 
written consent.
7.5 STATISTICAL ANALYSIS
The dose-response data for each patient before and 
after eradication were analysed using an 
exponential model V-Vmax (l-expc“bD) where V= output 
and dose of pentagastrin ( this model has previously
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been used by HIRSCHOWITZ et al ( 1984 ) . From this
analysis, estimates of Vfflax, ^-(ln 2/b) and
D5o=(Kin~c/b) were obtained, D5Q is the dose of
pentagastrin required to raise the output from basal to
50% of the estimated maximum and is the amount ofm
pentagastrin needed to raise the output to 50% of
maximum if basal output was zero. D5Q and are
measures of apparent and intrinsic sensitivity
respectively. A schematic representation of these
ideas is shown in Figure 17.
The data were fitted using BMDP ( PAR )( 1985 ).
Estimates of V„_v/ and from these fits weremax' m 50
only used in further analysis if the square of R 
(co-efficient of determination) was greater than 75%. 
Statistical testing was performed using Wilcoxon 
signed-ranks matched pairs and correlations by using 
Spearman Rank test with p<0.05 being taken as 
significant.
7.6 RESULTS
All the patients were cleared of H.pylori when 
they were reassessed one month after completion of 
therapy.
The median basal gastrin concentration was 4 8ng/l 
( range 22-77 ) before treatment and fell to
33ng/l ( range 8-37 ) (p=0.03) after eradication of
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Eradication of the infection did not produce any 
change in either the basal acid output or the acid 
output in response to the highest dose of pentagastrin 
( Table 11 ). The median basal acid output was 5.0 
mmol/h ( range 1.0-10.8 mmol/h ) before treatment and
4.6 mmol/h ( range 1.3- 9.0mmol/h ) after eradication 
of H. pylori . The median output to the highest dose of 
pentagastrin was 37.0 mmol/h (range 15.5- 63.8 mmol/h) 
before and 31.5 mmol/h ( range 18.0-66.0 mmol/h ) after 
eradication of H.pylori (Fig 18(a)). The acid output 
in response to the submaxima1 doses of pentagastrin was 
also similar before and after eradication of H.pylori 
(Table 11 ) . Analysis of dose-response showed that 
there was no significant change in either the maximum 
output of acid or the sensitivity to pentagastrin. The 
median estimated maximum acid output ( ) was 3 9.2
( range 15.2-63.3 ) before treatment and 32.3 ( range 
18.2-67.2 ) after treatment ( Fig 18(b)). The 95%
confidence intervals for the median fall was -3.1 to 
9.2 i.e. no significant change. Neither the intrinsic 
(Km ) or the apparent (D50) sensitivity showed a 
significant change. The median fall (and 95% confidence 
interval) in intrinsic sensitivity was 0.004 
(-0.019,0.019) ( Figure 19(a) ) and in apparent
sensitivity was 0.0007 (-0.015,0.016) ( Figure 19(b)). 
All the fits had coefficients of determination greater
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All the fits had coefficients of determination greater 
than 75%.
There was no correlation of basal plasma gastrin 
and basal acid output either before ( rs=-0.34,N.S.) or 
after (rs=0.16, N.S.) eradication of H.pylori . In
addition there was no correlation between basal serum 
gastrin and the value for [Km”D5 o^l either before 
(rs=-0.52,N.S.) or after ( rs=-0.18, N.S. ) eradication 
of H.pylori .
7.7 DISCUSSION
The mechanism of the increased gastrin 
concentration in chronic H.pylori infection is unclear. 
In this study we investigated the possibility that 
chronic H.pylori infection reduces the sensitivity of 
parietal cells to gastrin and consequently higher 
concentrations of the hormone are required to maintain 
the same level of acid secretion in the presence of the 
infection. The sensitivity of parietal cells to 
gastrin was assessed by measuring gastric acid 
secretion to graduated doses of pentagastrin and using 
the data to construct dose-response curves. This 
demonstrated that there was no difference in parietal 
cell sensitivity to pentagastrin following eradication 
of Htpylori.
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SECTION III
OVERALL DISCUSSION AND CONCLUSIONS
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CHAPTER 8
DISCUSSION AND CONCLUSIONS
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Helicobacter pylori infection of the gastric 
antrum is seen in over 90% of patients with duodenal 
ulceration ( O'CONNOR et al 1986, RAUWS et al 1988 ). 
Eradication of the infection results in a marked fall 
in ulcer relapse rate ( MARSHALL 1988, BORODY et al 
1988, SMITH et al 1988). The mechanism by which this 
infection predisposes to duodenal ulceration is not 
clear.
H.pylori only infects gastric epithelium and areas 
of gastric metaplasia. The predominant site of 
infection is the gastric antral epithelium which is the 
location of the gastrin producing G cells. Gastrin has 
an important role in gastric acid secretion and any 
alteration in its plasma concentration by H.pylori 
could result in a predisposition to duodenal 
ulceration. McCOLL et al ( 1991 ) examined the effect 
of eradication of H.pylori on basal and meal stimulated 
plasma gastrin concentrations in 10 duodenal ulcer 
patients. Eradication of the infection resulted in a 
33% fall in basal plasma gastrin and a 50% fall in the 
integrated gastrin response to an 0X0 meal. A similar 
fall in basal gastrin concentration was observed in 
children with various upper gastrointestinal disorders 
of H.pylori ( 0DERDA et al 1989 ). In duodenal ulcer
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subjects LEVI et al ( 1989 ) noted a similar fall in 
meal stimulated gastrin concentrations, 2 days after 
completion of H.pylori eradication therapy. These 
observations were confirmed in my studies (Chapters 5, 
7 and 8 ) . It is, therefore, possible that the
H.pylori infection by raising plasma gastrin 
concentration has a trophic effect on parietal cells 
and increases gastric acid output, thus predisposing to 
duodenal ulceration.
A large proportion of the general population is 
infected with H.pylori. The prevalence of the 
infection increases with age ( GRAHAM et al 1988 ) and 
varies in different parts of the world ( GRAHAM et al 
1991 ) with approximately 50% of adults in the western 
world being infected. Duodenal ulceration, however, 
affects only about 10% of the adults in the western 
world ( LANGMAN 1979 ). The reason why less than one 
in five people with H.pylori infection develops 
duodenal ulceration is not clear. I investigated the 
hypothesis that the development of duodenal ulceration 
is related to the degree of hypergastrinaemia induced 
by the chronic infection.
The results demonstrated that H.pylori infection 
raises plasma gastrin concentration in healthy 
volunteers as well as duodenal ulcer patients. This 
finding is consistent with that of SMITH et al (1990)
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who noted higher median integrated 24-h gastrin 
concentrations in eight volunteers,who had 
immunoglobulin ( Ig ) G antibodies to H.pylorir than in 
87 who were sero- negative. My, study also 
demonstrates that basal and meal stimulated gastrin 
concentrations in the H.pylori positive volunteers were 
not different from those in H.pylori positive duodenal 
ulcer patients. The development of duodenal ulceration 
in a minority of the population with H.pylori infection 
is therefore not a reflection of the degree of 
hypergastrinaemia induced by the infection. Other 
factors must, therefore, play a major role in the 
pathogenesis of ulcer disease.
The mechanism by which H .pylori infection raises 
plasma gastrin concentration is not known. It has been 
proposed by LEVI et al ( 1989 ) that the ammonia
produced by hydrolyses of urea by the organism's urease 
results in elevation of antral surface pH. The 
physiological inhibition of gastrin release by luminal 
acid is therefore lost resulting in elevation of the 
plasma gastrin concentration. In addition, ammonia may 
be a direct stimulus to gastrin release by the G cells. 
The hypergastrinaemia may be due to the chronic 
inflammation induced by H.pylori infection or 
physiological response to inhibition of parietal cell 
function by the infection.
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To determine whether the raised plasma gastrin 
concentrations seen with H.pylori infection is the 
result of ammonia production by H.pylorir I studied the 
effect of altering the rate of ammonia formation on 
plasma gastrin by infusing urea intragastrically. 
Increasing H.pylori ammonia production failed to change 
the plasma gastrin concentration. This does not lend 
support to the hypothesis that the hypergastrinaemia is 
caused by the ammonia. It seems unlikely that the 
degree of increase in ammonia production was inadequate 
as the rise in ammonium ion concentration at the antral 
epithelial surface, where the bacteria are found close 
to the gastrin secreting G cells, would have been 
greater than the three fold rise noted in the gastric 
aspirate. It should be stressed, however, that the 
failure to cause a further increase in gastrin by 
augmenting ammonia production does not exclude the 
possibility that the raised gastrin value was caused by 
the organism's ammonia production. The amount of 
ammonia produced by the bacterium under normal 
conditions may be sufficient to produce the maximum 
gastrin response via this mechanism.
My finding that augmenting H.pylori ammonia 
production failed to stimulate gastrin does not refute 
the hypothesis that the organism stimulates gastrin 
release by raising antral surface pH. The local
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alkalinising effect of H.pylori under basal conditions 
may already be sufficient to prevent suppression of 
gastrin release by gastric acid. In addition, the 
duration of the urea infusion in my study was four 
hours and earlier studies have shown that gastric 
alkalinisation was required for five hours before there 
was any rise in serum gastrin ( PETERS et al 1983 ). 
The effect of antral alkalinisation on serum gastrin in 
humans is controversial, however, as a more recent 
study could not detect any increase after raising 
gastric pH for 10 hours ( PETERSON et al 1986 ) .
This study also provides information on the 
regulation of H.pylori ammonia production in vivo. The 
almost undetectable intragastric concentrations of urea 
found before eradication of the organism and the rapid 
rise in the gastric ammonia concentration after the 
infusion of urea indicate that the gastric juice 
concentration of urea and its rate of diffusion across 
the gastric mucosa are factors that limit the 
generation of ammonia by H . pylori. It has been 
proposed that the organism's ammonia production is a 
means by which it protects itself from intragastric 
acid by producing a local alkaline micro-environment 
(GOODWIN et al 198 6). As gastric pH varies constantly 
and rapidly, one would expect such a protective 
mechanism to be under pH dependent control rather than
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under the control of substrate availability, which 
cannot be altered.
In an attempt to further elucidate the role of the 
urease enzyme in the increased plasma gastrin 
concentration seen in chronic H.pylori infection I 
performed the next study. The aim of this study was to 
examine plasma gastrin concentration soon after 
commencing H.pylori eradication therapy. At this early 
time I hoped to achieve complete suppression of 
bacterial urease activity without significant 
resolution of the antral gastritis. The latter has 
been postulated as another possible mechanism by which 
the infection raises plasma gastrin.
The triple therapy, ( tripotassium dicitrato 
bismuthate, amoxycillin and metronidazole ) used in 
this study, produced complete suppression of the 
bacterial urease activity. This is not surprising as 
bismuth has been shown to be a powerful inhibitor of 
H.pylori urease activity as well being bactericidal 
(SAROSIEK et al 1990) . My observation that this degree 
of suppression of H.pylori urease activity did not 
result in a fall in basal plasma gastrin or meal 
stimulated gastrin response does not support the 
hypergastrinaemia being directly related to the 
bacterial urease activity. If the hypergastrinaemia 
were due to elevation of antral surface pH by bacterial
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ammonia, the hormone level should fall rapidly 
following suppression of ammonia production and thereby 
fall in antral surface pH. In patients with grossly 
elevated gastrin concentrations due to achlorhydria, 
intragastric instillation of hydrochloric acid causes 
the plasma gastrin to fall within 5-15 minutes ( YALOW 
et al 1970 ).
The possibility must be considered that the 
antibacterial therapy could have independently 
stimulated gastrin release and thus obscured a fall in 
gastrin due to their suppression of urease activity. 
However, the absence of any rise in gastrin following 
24h triple therapy in the H.pylori negative controls 
excludes this.
The findings in this study are consistent with 
those of El NUJUMI et al ( 1991 ) who observed that 
inhibiting H.pylori urease activity with 
acetohydroxamic acid did not lower the serum gastrin 
concentration in duodenal ulcer patients. In this 
study with acetohydroxamic acid only partial 
suppression of urease activity was achieved [ median 20 
minute value of the l4C-urea breath test 22 ( range
14-95 ) ] and there was the possibility that the
suppression of ammonia production may have been 
inadequate to produce a fall in serum gastrin. In the 
present study, with 24 hours triple therapy, the urease
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activity, as assessed by the 14C-urea breath test, was 
suppressed to a median value of 5 ( range 2- 15 ) which 
was similar to the value 2 ( range 0-5 ) previously
observed in patients one month post eradication. The 
lack of association between H.pylori urease activity 
and serum gastrin in these studies is also consistent 
with the previous observation that augmenting H.pylori 
ammonia production by administering urea did not raise 
gastrin in duodenal ulcer subjects.
It is now necessary to consider alternative 
explanations for the hypergastrinaemia. It is possible 
that it is related to the effects on the antral G cells 
of the chronic inflammation that H.pylori infection 
induces in the antral mucosa. At 28 hours after 
commencing anti-H .pylori therapy there was already 
early resolution of the antral gastritis but no change 
in the gastrin concentration. The change in the 
gastritis score, however, only affected the degree of 
infiltration of the epithelium and lamina propria with 
polymorphonuclear cells and there was no change in the 
chronic inflammatory infiltrate. It has been shown in 
isolated perfused canine antrum that the T lymphocyte 
products, Interleukin-2 and Gamma interferon, stimulate 
gastrin release ( TEICHMANN et al 1986 ) . It is
possible that resolution of the chronic inflammatory 
infiltrate is required before a change in the plasma
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gastrin concentration can be observed.
Urease has been proposed as being essential for 
the survival of H.pylori in the low pH environment of 
the stomach ( GOODWIN et al 1986 ) . By making ammonia 
the organism is thought to make the pH of its 
environment more favorable to its survival. Despite 
total suppression of urease activity in all the 
patients with triple therapy, eradication was achieved 
in only 4 of them. This indicates that urease activity 
is not essential for the organism's survival once the 
infection is established within the gastric mucosa 
layer. It does not, however, exclude the possibility 
that the organism's ammonia production protects it from 
gastric acid when the infection is first being 
contracted.
This study indicates that the hypergastrinaemia in 
patients with H.pylori infection is not directly linked 
to the bacterial urease activity and ammonia 
production. It also highlights the rapid rate of 
resolution of the acute inflammatory cell component of 
the antral gastritis following commencement of 
anti-H.pylori therapy.
The hypothesis proposing that ammonia produced by 
the bacterium's urease enzyme raises antral surface pH 
and thus stimulates gastrin release (LEVI et al 1989) 
was further tested in my next study. Here, I
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investigated the influence of H.pylori infection on the 
gastrin response to antral alkalinisation under both 
basal and meal stimulated conditions in duodenal ulcer 
subjects.
There are conflicting reports concerning the 
effect of alkalinisation of the antrum,during fasting, 
on gastrin release in man. Several studies have 
reported that acute elevation of antral pH does not 
alter the serum gastrin concentration ( LEVANT et al 
1973, HIGGS et al 1974, KLINE et al 1975, FELDMAN et al 
1978 ) . SVENSSON et al ( 1979 ) failed to observe any 
rise in gastrin after maintaining antral alkalinisation 
for 3 hours and likewise PETERSEN et al ( 1986 ) found 
no change even after 10 hours in duodenal ulcer 
subjects. However, PETERS et al ( 1983 ) noted that 
maintaining antral pH above 6 for 5 hours produced an 
increase in serum gastrin; in those with duodenal 
ulceration it increased from 53 pg/ml to 71 pg/ml 
representing a rise of 3 5% and in the healthy controls 
from 25 pg/ml to 37.5 pg/ml representing an increase of 
50%. HANSKY et al ( 1971 ) also reported an increase 
in serum gastrin in both duodenal ulcer subjects and 
healthy volunteers which was apparent within 30 minutes 
of alkalinisation. These conflicting studies were all 
conducted before H.pylori infection was recognised and 
its effect on gastrin release appreciated.
99
In this study I have demonstrated that the fall in 
gastrin is equally pronounced when the intragastric pH 
is maintained above 6. When the peptone meal is taken 
without alkalinisation the buffering effect of the meal 
raises the intragastric pH above 2 for less than 15 
minutes ( McCOLL et al 1991 ) . If H.pylori raised 
plasma gastrin by elevating antral surface pH, the 
difference in plasma gastrin concentrations between 
H.pylori positive and eradicated patients would largely 
or completely disappear when examined at neutral pH. 
The finding that the difference remained the same at 
neutral pH indicates that H.pylori induced 
hypergastrinaemia is not due to elevation of antral 
surface pH.
Alkalinisation of the antrum has an immediate 
effect on the meal stimulated gastrin response ( WALSH 
et al 1975 ) and this is consistent with the finding 
that the gastrin response to the meal was increased by 
alkalinisation. The finding that alkalinisation of the 
antrum increased the meal stimulated gastrin response 
to a similar degree in the presence and absence of 
H.pylori again excludes H.pylori induced 
hypergastrinaemia being due to elevation of antral 
surface pH. The reason for two of the subjects not 
showing increased gastrin response to alkalinisation 
either before or after eradication of H .pylori is
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unclear.
The studies of the effect of alkalinisation 
without a meal also showed a similar response before 
and after eradication of H.pylori. If basal gastrin 
concentration were raised due to elevation of antral 
surface pH by H.pylorif raising intragastric pH should 
produce less of a rise in plasma gastrin concentration 
before than after eradication of H.pylori and the 
plasma gastrin level achieved after 5 hours of 
alkalinisation should be similar on both occasions. 
However, I, found that the % change in the plasma 
gastrin with alkalinisation was similar in the presence 
or absence of H.pylori and the gastrin levels achieved 
after 5 hours remained higher in the H.pylori positive 
group.
The finding that the percentage rise in gastrin 
induced by H.pylori is independent of intragastric pH 
is consistent with recent studies in patients receiving 
therapy with the H+/K= ATPase inhibitor pantoprazole 
(McCOLL et al 1992) . It was noted that the serum 
gastrin concentration during this acid inhibitory 
therapy was higher in the H.pylori positive subjects 
than in the H.pylori eradicated ones and the difference 
between them was similar before and during acid 
inhibitory therapy.
The findings of the present study,that H.pylori
101
induced hypergastrinaemia is not due to elevated antral 
surface pH is consistent with the previous studies in 
which I found no association between the organism*s 
urease activity and gastrin concentration. Neither 
increasing the organism's ammonia production by 
intragastric urea infusion, nor inhibiting it with 
acetohydroxamic acid ( El NUJUMI et al 1991 ) nor
completely suppressing it with 24 hours triple therapy 
alters the plasma gastrin concentration.
Acute H.pylori infection produces hypochlorhydria 
which persists for several months (GRAHAM et al 1988) . 
In vitro studies have demonstrated that the organism 
produces a substance that inhibits parietal cell 
function. It is therefore possible that the
hypergastrinaemia induced by chronic H.pylori infection 
is a physiological response to reestablish normal acid 
secretion. To investigate this, I have examined the 
effect of eradicating H .pylori on the parietal cell 
sensitivity to pentagastrin in duodenal ulcer patients. 
In this study the sensitivity of parietal cells to 
gastrin was assessed by measuring gastric acid 
secretion to graduated doses of pentagastrin and using 
the data to construct dose-response curves. This 
showed that there was no difference in parietal cell 
sensitivity to pentagastrin after eradication of 
Htpylori.
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One practical difficulty in calculating parietal 
cell sensitivity from the acid response to graduated 
doses of pentagastrin concerns basal acid output. It 
is difficult to know whether the basal acid output 
should be plotted against the zero dose of pentagastrin 
or should be subtracted from the outputs at each 
pentagastrin dose and itself excluded from the 
sensitivity calculations ( PETERSEN et al 1975 ). This 
consideration is important when the basal acid output 
values are different in the two groups being compared- 
for example, duodenal ulcer patients versus healthy 
volunteers- but is less important in the present study, 
in which the basal acid output was similar before and 
after eradication of H . pylori. To allow for this 
potential problem, we adopted the method of HIRSCHOWITZ 
( 1984 ). This calculates both the apparent
sensitivity ( D50 )- that is, the dose of pentagastrin 
required to raise the output from basal to 50% of 
estimated maximum- and the intrinsic sensitivity ( Km)- 
that is, the dose needed to raise the output to 50% of 
maximum if basal output was zero. The estimated 
sensitivity to pentagastrin was unchanged after 
eradication of H.pylori irrespective of whether it was 
calculated as the apparent or intrinsic sensitivity.
Studies comparing parietal cell sensitivity with 
gastrin in duodenal ulcer patients and healthy
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volunteers have produced conflicting conclusions. Some 
have demonstrated an increased sensitivity ( ISENBERG 
et al 1975, LAM et al 1980 ) whereas others have found 
no difference ( PETERSEN et al 1975, KOFFMAN et al 
1977, HIRSCHOWITZ 1984, HIRSCHOWITZ et al 1985 ). The 
present study indicates that these conflicting findings 
cannot be attributed to varying H.pylori status of the 
subjects studied. This study, however, cannot exclude 
the possibility that the H.pylori infection produces an 
alteration in parietal cell sensitivity which does not 
resolve within 1 month of eradicating the infection. 
It does, however, exclude the possibility that the 
increased gastrin is due to reduced parietal cell 
sensitivity, as the gastrin fell within the time period 
of the study.
Although my study indicates that H.pylori 
infection does not reduce parietal cell sensitivity to 
gastrin in duodenal ulcer patients, we cannot exclude 
that this is also the case in all subjects with the 
infection. The reason why only a small proportion of 
individuals with H.pylori develop duodenal ulcers is 
unclear. As described earlier, the degree of 
hypergastrinaemia induced by H.pylori is similar in 
duodenal ulcer patients and healthy volunteers, yet 
acid secretion is known to be higher in the former. It 
is possible that healthy volunteers with H.pylori have
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a more marked body gastritis, impairing their acid 
response to the hypergastrinaemia and thus protecting 
them from duodenal ulceration. In contrast, duodenal 
ulcer subjects with H.pylori have both an elevated 
gastrin and an unimpaired acid response to gastrin, as 
shown by the present study.
The mechanism by which H.pylori infection raises 
plasma gastrin remains unclear. LEVI et al ( 1989 ) 
postulated that it was due to the elevation of antral 
surface pH by the organism's ammonia production, but my 
earlier studies have indicated that this is not the 
case. The present study indicates that the
hypergastrinaemia in duodenal ulcer patients with
H.pylori is not a compensatory response to impaired 
parietal cell function.
In the light of these studies the most likely 
explanation for the hypergastrinaemia is that it is 
caused by the inflammation the infection induces in the 
antral mucosa. Studies using isolated perfused canine 
antrum have shown that the T-lymphocyte products 
interleukin-2 and gamma-interferon stimulate gastrin 
release ( TEICHMANN et al 1986 ) . The inflammatory 
process could cause the hypergastrinaemia by a direct 
stimulatory effect on the antral G cells or indirectly 
by inhibiting the release of somatostatin by the antral 
D cells.
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RECENT DEVELOPMENTS
Research in the field of Helicobacter pylori infection is proceeding at a very rapid rate. Due 
to this there have been several key developments since the completion of the work in this thesis 
and these are therefore appended below.
(1) More effective eradication regimens have become available for treating H pylori 
infection. It is now possible to achieve eradication rates of more than 90% with a single 
week’s treatment. The currently most commonly used eradication regimen consists of 
omeprazole 40mg per day plus metronidazole 400mg t.i.d. and amoxycillin 500mg t.i.d., 
all given for seven days(1).
(2) There have been rapid advances as a result of the application of molecular biology to the
field of gastrin metabolism. In particular, the gene for the gastrin receptor has now been 
cloned(2).
(3) Several recent publications have demonstrated that Hpylori lowers the concentration of
somatostatin in the antral mucosa and also lowers the levels of somatostatin messenger 
RNA in antral mucosa(3 7). The release of gastrin is under physiological suppression by 
somatostatin and thus the increased gastrin release is likely to be explained by these 
decreased synthesis of somatostatin. The mechanism by which Hpylori lowers antral 
somatostatin remains unclear.
(4) Recent studies have highlighted the importance of the H pylori induced 
hypergastrinaemia by demonstrating that it is associated with markedly increased gastric 
acid secretion(8). These recent studies have been performed by using gastrin releasing 
peptide as the stimulant to gastric acid secretion. This neuropeptide stimulates release of 
gastrin from the G-cells in the antral mucosa and this gastrin then circulates and 
stimulates the parietal cells in the body of the stomach to secrete acid. Gastrin releasing 
peptide also stimulates the release of a variety of inhibitory peptides which regulate the 
degree of gastrin release and also of the acid response to the gastrin. Gastrin releasing
1
peptide stimulates the response to a meal by measuring the combined functional response 
of the antrum and body of the stomach and also by activating both stimulatory and 
inhibitory control pathways. Studies employing gastrin releasing peptides have indicated 
that duodenal ulcer patients with H pylori infection have a six-fold increased acid 
response compared to uninfected controls. In addition, eradication of the infection results 
in complete normalisation of the acid response(9).
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